Globalstar (GSAT) 10-Q 12 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 08, 2019	Oct. 25, 2019
Document and Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Entity Registrant Name	Globalstar, Inc.
Entity Central Index Key	0001366868
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Current Reporting Status	Yes
Voting Common Stock
Document and Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		1,451,653,498
Nonvoting Common Stock
Document and Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)			0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue:
Revenue	$ 38,614	$ 35,692	$ 99,883	$ 98,167
Operating expenses:
Marketing, general and administrative	12,895	15,061	35,523	42,280
Revision to contract termination charge	0	0	0	(20,478)
Depreciation, amortization and accretion	24,026	24,738	71,679	66,585
Total operating expenses	50,619	53,654	146,875	127,139
Operating loss	(12,005)	(17,962)	(46,992)	(28,972)
Other income (expense):
Interest income and expense, net of amounts capitalized	(14,471)	(13,358)	(40,149)	(31,016)
Derivative gain	50,156	39,059	142,280	145,944
Gain on legal settlement	0	0	120	6,779
Other	(2,529)	1,331	(2,064)	(2,682)
Total other income (expense)	33,156	27,032	100,187	119,025
Income before income taxes	21,151	9,070	53,195	90,053
Income tax expense	40	51	124	116
Net income	21,111	9,019	53,071	89,937
Other comprehensive income (loss):
Foreign currency translation adjustments	1,022	500	254	2,800
Comprehensive income (loss)	$ 22,133	$ 9,519	$ 53,325	$ 92,737
Net income (loss) per common share:
Basic (USD per share)	$ 0.01	$ 0.01	$ 0.04	$ 0.07
Diluted (USD per share)	$ (0.01)	$ (0.02)	$ (0.05)	$ (0.03)
Weighted-average shares outstanding:
Basic (in shares)	1,451,703	1,264,516	1,450,146	1,263,416
Diluted (in shares)	1,647,734	1,427,800	1,647,267	1,448,920
Service revenue
Revenue:
Revenue	$ 34,152	$ 29,898	$ 86,971	$ 83,903
Operating expenses:
Cost of goods and services	9,216	9,429	28,464	27,984
Subscriber equipment sales
Revenue:
Revenue	4,462	5,794	12,912	14,264
Operating expenses:
Cost of goods and services	$ 4,482	$ 4,426	$ 11,209	$ 10,768

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 26,225	$ 15,212
Restricted cash	61,224	60,278
Accounts receivable, net of allowance of $3,162 and $3,382, respectively	20,909	19,327
Inventory	17,240	14,274
Prepaid expenses and other current assets	20,916	13,410
Total current assets	146,514	122,501
Property and equipment, net	820,315	882,695
Operating lease right of use assets, net	16,270	0
Intangible and other assets, net of accumulated amortization of $8,706 and $7,930, respectively	36,744	40,286
Total assets	1,019,843	1,045,482
Current liabilities:
Current portion of long-term debt	98,829	96,249
Accounts payable	5,019	6,995
Accrued expenses	36,839	23,085
Payables to affiliates	353	656
Derivative liabilities	129	757
Deferred revenue	27,839	31,938
Total current liabilities	169,008	159,680
Long-term debt, less current portion	402,468	367,202
Operating lease liabilities	15,158	0
Employee benefit obligations	4,619	4,489
Derivative liabilities	4,456	146,108
Deferred revenue	5,261	5,692
Other non-current liabilities	2,731	3,366
Total non-current liabilities	434,693	526,857
Contingencies (Note 8)
Stockholders’ equity:
Preferred Stock	0	0
Additional paid-in capital	1,941,236	1,937,364
Accumulated other comprehensive loss	(3,585)	(3,839)
Retained deficit	(1,521,654)	(1,574,725)
Total stockholders’ equity	416,142	358,945
Total liabilities and stockholders’ equity	1,019,843	1,045,482
Series A Preferred Convertible Stock
Stockholders’ equity:
Preferred Stock	0	0
Voting Common Stock
Stockholders’ equity:
Common Stock	145	145
Nonvoting Common Stock
Stockholders’ equity:
Common Stock	$ 0	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Accounts receivable, allowance	$ 3,162	$ 3,382
Accumulated Amortization of Intangible and other assets	$ 8,706	$ 7,930
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Series A Preferred Convertible Stock
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Voting Common Stock
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,900,000,000	1,500,000,000
Common stock, shares issued (in shares)	1,451,635,661	1,446,783,645
Common stock, shares outstanding (in shares)	1,451,635,661	1,446,783,645
Nonvoting Common Stock
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	0	400,000,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Deficit
Beginning balance (in shares) at Dec. 31, 2017		1,261,949
Beginning balance, amount at Dec. 31, 2017	$ 291,224	$ 126	$ 1,869,339	$ (6,939)	$ (1,571,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Contribution of services	137		137
Net issuance of restricted stock awards and recognition of stock-based compensation (in shares)		1,165
Net issuance of restricted stock awards and recognition of stock-based compensation	1,853		1,853
Recognition of stock-based compensation of employee stock purchase plan	84		84
Other comprehensive loss	(330)			(330)
Net income (loss)	87,930				87,930
Ending balance (in shares) at Mar. 31, 2018		1,263,114
Ending balance, amount at Mar. 31, 2018	383,991	$ 126	1,871,413	(7,269)	(1,480,279)
Beginning balance (in shares) at Dec. 31, 2017		1,261,949
Beginning balance, amount at Dec. 31, 2017	291,224	$ 126	1,869,339	(6,939)	(1,571,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	89,937
Ending balance (in shares) at Sep. 30, 2018		1,265,622
Ending balance, amount at Sep. 30, 2018	392,100	$ 127	1,874,384	(4,139)	(1,478,272)
Beginning balance (in shares) at Mar. 31, 2018		1,263,114
Beginning balance, amount at Mar. 31, 2018	383,991	$ 126	1,871,413	(7,269)	(1,480,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Contribution of services	137		137
Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation (in shares)		716
Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation	545		545
Net issuance of restricted stock awards and recognition of stock-based compensation (in shares)		275
Net issuance of restricted stock awards and recognition of stock-based compensation	1,052		1,052
Other comprehensive loss	2,630			2,630
Net income (loss)	(7,012)				(7,012)
Ending balance (in shares) at Jun. 30, 2018		1,264,105
Ending balance, amount at Jun. 30, 2018	381,343	$ 126	1,873,147	(4,639)	(1,487,291)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Contribution of services	107		107
Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation (in shares)		200
Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation	200		200
Net issuance of restricted stock awards and recognition of stock-based compensation (in shares)		1,317
Net issuance of restricted stock awards and recognition of stock-based compensation	931	$ 1	930
Other comprehensive loss	500			500
Net income (loss)	9,019				9,019
Ending balance (in shares) at Sep. 30, 2018		1,265,622
Ending balance, amount at Sep. 30, 2018	392,100	$ 127	1,874,384	(4,139)	(1,478,272)
Beginning balance (in shares) at Dec. 31, 2018		1,446,784
Beginning balance, amount at Dec. 31, 2018	358,945	$ 145	1,937,364	(3,839)	(1,574,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances (forfeitures) of restricted stock awards, stock for employee stock option exercises and recognition of stock-based compensation (in shares)		3,285
Issuances (forfeitures) of restricted stock awards, stock for employee stock option exercises and recognition of stock-based compensation	1,000		1,000
Contribution of services	47		47
Recognition of stock-based compensation of employee stock purchase plan	77		77
Stock offering issuance costs	(195)		(195)
Other comprehensive loss	(270)			(270)
Net income (loss)	25,771				25,771
Ending balance (in shares) at Mar. 31, 2019		1,450,069
Ending balance, amount at Mar. 31, 2019	385,375	$ 145	1,938,293	(4,109)	(1,548,954)
Beginning balance (in shares) at Dec. 31, 2018		1,446,784
Beginning balance, amount at Dec. 31, 2018	358,945	$ 145	1,937,364	(3,839)	(1,574,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	53,071
Ending balance (in shares) at Sep. 30, 2019		1,451,636
Ending balance, amount at Sep. 30, 2019	416,142	$ 145	1,941,236	(3,585)	(1,521,654)
Beginning balance (in shares) at Mar. 31, 2019		1,450,069
Beginning balance, amount at Mar. 31, 2019	385,375	$ 145	1,938,293	(4,109)	(1,548,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances (forfeitures) of restricted stock awards, stock for employee stock option exercises and recognition of stock-based compensation (in shares)		232
Issuances (forfeitures) of restricted stock awards, stock for employee stock option exercises and recognition of stock-based compensation	968		968
Contribution of services	197		197
Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation (in shares)		1,437
Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation	500		500
Investment in business	155		155
Other comprehensive loss	(498)			(498)
Net income (loss)	6,189				6,189
Ending balance (in shares) at Jun. 30, 2019		1,451,738
Ending balance, amount at Jun. 30, 2019	392,886	$ 145	1,940,113	(4,607)	(1,542,765)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances (forfeitures) of restricted stock awards, stock for employee stock option exercises and recognition of stock-based compensation (in shares)		(102)
Issuances (forfeitures) of restricted stock awards, stock for employee stock option exercises and recognition of stock-based compensation	966		966
Contribution of services	47		47
Recognition of stock-based compensation of employee stock purchase plan	110		110
Other comprehensive loss	1,022			1,022
Net income (loss)	21,111				21,111
Ending balance (in shares) at Sep. 30, 2019		1,451,636
Ending balance, amount at Sep. 30, 2019	$ 416,142	$ 145	$ 1,941,236	$ (3,585)	$ (1,521,654)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows provided by (used in) operating activities:
Net income	$ 53,071	$ 89,937
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation, amortization and accretion	71,679	66,585
Change in fair value of derivative assets and liabilities	(142,280)	(145,944)
Stock-based compensation expense	4,140	4,218
Amortization of deferred financing costs	9,136	6,349
Provision for bad debts	1,436	964
Noncash interest and accretion expense	13,932	10,275
Revision to contract termination charge	0	(20,478)
Change to estimated impact upon adoption of ASC 606	(3,885)	0
Unrealized foreign currency loss	1,213	2,479
Other, net	344	979
Changes in operating assets and liabilities:
Accounts receivable	(3,249)	(4,486)
Inventory	(4,267)	1,383
Prepaid expenses and other current assets	(3,151)	(4,326)
Other assets	(211)	(3,756)
Accounts payable and accrued expenses	9,042	12,350
Payables to affiliates	(304)	420
Other non-current liabilities	57	(1,027)
Deferred revenue	(659)	3,846
Net cash provided by operating activities	6,044	19,768
Cash flows provided by (used in) investing activities:
Second-generation network costs (including interest)	(1,350)	(5,887)
Property and equipment additions	(3,480)	(5,346)
Investment in business	155	0
Purchase of intangible assets	(2,950)	(1,948)
Net cash used in investing activities	(7,625)	(13,181)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	(47,435)	(38,933)
Payments for financing costs	(1,401)	0
Proceeds from Subordinated Loan Agreement	62,000
Proceeds from issuance of common stock and exercise of options and warrants	402	395
Net cash provided by (used in) financing activities	13,566	(38,538)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(26)	68
Net increase (decrease) in cash, cash equivalents and restricted cash	11,959	(31,883)
Cash, cash equivalents and restricted cash, beginning of period	75,490	105,279
Cash, cash equivalents and restricted cash, end of period	87,449	73,396
Reconciliation of cash, cash equivalents and restricted cash
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	75,490	105,279
Supplemental disclosure of cash flow information:
Cash paid for interest	12,922	12,109
Supplemental disclosure of non-cash financing and investing activities:
Increase in capitalized accrued interest for second-generation network costs	364	1,974
Capitalized accretion of debt discount and amortization of prepaid financing costs	$ 280	$ 1,825

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	1. BASIS OF PRESENTATION Globalstar, Inc. (“Globalstar” or the “Company”) provides Mobile Satellite Services (“MSS”) including voice and data communications services through its global satellite network. Thermo Companies, through commonly controlled affiliates, (collectively, “Thermo”), is the principal owner and largest stockholder of Globalstar. The Company’s Executive Chairman of the Board controls Thermo. Two other members of the Company's Board of Directors are also directors, officers or minority equity owners of various Thermo entities. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information. Certain information and footnote disclosures normally in financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”); however, management believes the disclosures made are adequate to make the information presented not misleading. These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Globalstar Annual Report on Form 10-K for the year ended December 31, 2018 , as filed with the SEC on February 28, 2019 (the “ 2018 Annual Report”), and Management's Discussion and Analysis of Financial Condition and Results of Operations herein. The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from estimates. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation and income taxes. The Company has made certain reclassifications to prior period condensed consolidated financial statements to conform to current period presentation. These unaudited interim condensed consolidated financial statements include the accounts of Globalstar and all its subsidiaries. All significant intercompany transactions and balances have been eliminated in the consolidation. In the opinion of management, the information included herein includes all adjustments, consisting of normal recurring adjustments, that are necessary for a fair presentation of the Company’s condensed consolidated statements of operations, condensed consolidated balance sheets, condensed consolidated statements of stockholders' equity and condensed consolidated statements of cash flows for the periods presented. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the full year or any future period. Recently Issued Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) No. 2016-13, Credit Losses, Measurement of Credit Losses on Financial Instruments . ASU No. 2016-13, as amended, significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard will replace today’s incurred loss approach with an expected loss model for instruments measured at amortized cost. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted for all entities for annual periods beginning after December 15, 2018, and interim periods therein. The Company has not yet determined the impact this standard will have on its financial statements and related disclosures. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement . As part of the FASB's disclosure framework project, it has eliminated, amended and added disclosure requirements for fair value measurements. Entities will no longer be required to disclose the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy, the policy of timing of transfers between levels of the fair value hierarchy and the valuation processes for Level 3 fair value measurements. Public companies will be required to disclose the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of any interim or annual reporting period. This ASU will have an impact on the Company's disclosures. In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans . As part of the FASB's disclosure framework project, it has changed the disclosure requirements for defined pension and other post-retirement benefit plans. The FASB eliminated disclosure requirements related to the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year, the amount and timing of plan assets expected to be returned to the employer, if any, information related to Japanese Welfare Pension Insurance Law, information about the amount of future annual benefits covered by insurance contracts and significant transactions between the employer or related parties and the plan, and the disclosure of the effects of a one-percentage-point change in the assumed health care cost trend rates on the (1) aggregate of the service and interest cost components of net periodic benefit costs and the (2) benefit obligation for postretirement health care benefits. Entities will be required to disclose the weighted-average interest crediting rate for cash balance plans and other plans with promised interest crediting rates as well as an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. This ASU is effective for public entities for annual periods beginning after December 15, 2020. Early adoption is permitted as of the beginning of any annual reporting period. This ASU will have an impact on the Company's disclosures. In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . This ASU requires companies to defer specified implementation costs in a cloud computing arrangement that are often expensed under current US GAAP and recognize these costs to expense over the noncancellable term of the arrangement. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's financial statements and related disclosures. Recently Issued Financial Reporting Rules In April 2019, the SEC adopted the final rules under SEC Releases 33-10618 and 34-85381, FAST Act Modernization and Simplification of Regulation S-K. Among other things, the amendments 1) allow registrants who present financial statements covering three years in their periodic reports to omit discussion of the earliest year from management's discussion and analysis if the discussion was included in a prior filing, 2) allow registrants to omit certain information and exhibits from their periodic reports without submitting confidential treatment requests to the Commission, 3) clarify and streamline certain risk factor and property disclosure requirements, 4) require all filings to include hyperlinks to information that is incorporated by reference in current filings to the information available on EDGAR, as applicable, and 5) require registrants to apply XBRL tags to certain information on cover pages of SEC filings. Certain of the amended rules became effective April 2, 2019 or May 2, 2019 and have been applied to any filings after these dates, except for the XBRL tagging requirement, which is effective for large accelerated and accelerated filers for fiscal reports ending on or after June 15, 2019 and 2020, respectively. The Company does not expect these final rules to have a material impact on its disclosures and financial statements. Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases . ASU 2016-02 became effective for annual reporting periods beginning after December 15, 2018. ASU 2016-02 amended the FASB Accounting Standards Codification (“ASC”) and created a new ASC Topic 842, “Leases” (“ASC 842”). The Company adopted this standard on January 1, 2019. See Note 3: Leases for further discussion, including the impact on the Company's condensed consolidated financial statements and required disclosures. In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . This guidance allows companies to reclassify items in accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the H.R.1, “An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018” (the “Tax Act”) (previously known as “The Tax Cuts and Jobs Act”). This ASU is effective for all entities for annual and interim periods beginning after December 15, 2018. The Company adopted this standard on January 1, 2019. The adoption of this standard did not have a material effect on the Company's financial statements or related disclosures. In June 2018, the FASB issued ASU No. 2018-07, Compensation - Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting . ASU 2018-07 aligns the accounting for share-based payment awards issued to employees and nonemployees. Measurement of equity-classified nonemployee awards will now be valued on the grant date and will no longer be remeasured through the performance completion date. This amendment also changes the accounting for nonemployee awards with performance conditions to recognize compensation cost when achievement of the performance condition is probable, rather than upon achievement of the performance condition, as well as eliminating the requirement to reassess the equity or liability classification for nonemployee awards upon vesting, except for certain award types. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2018. The Company adopted this standard on January 1, 2019. The adoption of this standard did not have a material effect on the Company's financial statements or related disclosures.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Revenue	2. REVENUE Disaggregation of Revenue The following table discloses revenue disaggregated by type of product and service (amounts in thousands): Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Service revenue: Duplex $ 16,589 $ 12,213 $ 34,265 $ 31,130 SPOT 12,482 12,957 38,196 39,787 Commercial IoT 4,526 3,542 12,577 9,847 IGO 139 257 484 682 Other 416 929 1,449 2,457 Total service revenue 34,152 29,898 86,971 83,903 Subscriber equipment sales: Duplex $ 349 $ 436 $ 906 $ 1,618 SPOT 1,880 2,970 5,657 6,455 Commercial IoT 2,182 2,356 6,226 6,067 Other 51 32 123 124 Total subscriber equipment sales 4,462 5,794 12,912 14,264 Total revenue $ 38,614 $ 35,692 $ 99,883 $ 98,167 The Company attributes equipment revenue to various countries based on the location where equipment is sold. Service revenue is generally attributed to the various countries based on the Globalstar entity that holds the customer contract. The following table discloses revenue disaggregated by geographical market (amounts in thousands): Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Service revenue: United States $ 23,155 $ 21,096 $ 61,859 $ 59,581 Canada 7,914 5,723 16,057 15,003 Europe 2,251 2,462 6,585 7,113 Central and South America 680 527 1,814 1,708 Others 152 90 656 498 Total service revenue 34,152 29,898 86,971 83,903 Subscriber equipment sales: United States $ 2,435 $ 4,148 $ 7,195 $ 9,202 Canada 1,290 907 3,236 2,050 Europe 371 326 1,388 1,755 Central and South America 345 370 1,006 1,096 Others 21 43 87 161 Total subscriber equipment sales 4,462 5,794 12,912 14,264 Total revenue $ 38,614 $ 35,692 $ 99,883 $ 98,167 During the third quarter of 2019, the Company changed its calculation of the estimated impact from the initial adoption of ASC Topic 606, "Revenue from Contracts with Customers" ("ASC 606") on January 1, 2018. In accordance with ASC 606, the Company accrues contract breakage to revenue based on historical usage patterns. The original calculation of the adoption impact did not reduce deferred revenue and retained deficit enough for revenue that would have been recognized under ASC 606 for contracts that were open at the adoption date. This adjustment was immaterial to the Company’s financial statements for each period since January 1, 2018. Accordingly, the Company recorded a cumulative adjustment to service revenue during the third quarter of 2019; this adjustment included an out-of-period amount of $3.9 million . Contract Balances The following table discloses information about accounts receivable, costs to obtain a contract (as recorded in intangible and other assets, net on the Company's condensed consolidated balance sheet), and contract liabilities (as recorded in both current and long-term deferred revenue on the Company's condensed consolidated balance sheet) from contracts with customers (amounts in thousands): September 30, 2019 December 31, 2018 Accounts receivable $ 20,909 $ 19,327 Capitalized costs to obtain a contract 1,974 2,018 Contract liabilities 33,100 37,630 Accounts Receivable Included in the accounts receivable balance in the table above are contract assets, which represent primarily unbilled amounts related to performance obligations satisfied by the Company of $1.6 million and $0.7 million as of September 30, 2019 and December 31, 2018 , respectively. The Company has agreements with certain of its independent gateway operators ("IGOs") whereby the parties net settle outstanding payables and receivables between the respective entities on a periodic basis. As of September 30, 2019 , and December 31, 2018 , $6.0 million and $7.8 million , respectively, related to these agreements was included in accounts receivable on the Company’s condensed consolidated balance sheet. The reduction in this accounts receivable balance from December 31, 2018 resulted primarily from the write-off of the receivable due from the Company's Mexican IGO partner following that gateway being shut down during 2019 and the settlement of the receivable due from the Argentinian IGO partner following the acquisition of their MSS license by Globalstar in 2019. Impairment losses on receivables include both provisions for bad debt and the reversal of revenue for accounts where collectability is not reasonably assured. During the three months ended September 30, 2019 and 2018 , impairment loss on receivables from contracts with customers was $1.0 million and $0.4 million , respectively. During the nine months ended September 30, 2019 and 2018 , impairment loss on receivables from contracts with customers was $3.7 million and $2.2 million , respectively. The increase in the impairment loss on receivables during the nine months ended September 30, 2019 compared to the same period in 2018 was driven primarily by a specific reserve related to one of the Company's IGOs, which the Company recorded during the quarter ended March 31, 2019. Costs to Obtain a Contract The Company also capitalizes costs to obtain a contract, which include certain deferred subscriber acquisition costs that are amortized consistently with the pattern of transfer of the good or delivery of the service to which the asset relates. The Company’s subscriber acquisition costs primarily include dealer and internal sales commissions and certain other costs, including but not limited to, promotional costs, cooperative marketing credits and shipping and fulfillment costs. The Company capitalizes incremental costs to obtain a contract to the extent it expects to recover them. These capitalized contract costs include only internal and external initial activation commissions because these costs are considered incremental and would not have been incurred if the contract had not been obtained. These capitalized costs are included in other assets on the Company’s condensed consolidated balance sheet and are amortized to marketing, general and administrative expenses on the Company’s condensed consolidated statement of operations on a straight-line basis over the estimated customer life of three years, which considers anticipated contract renewals. For the three months ended September 30, 2019 and 2018 , the amount of amortization related to capitalized costs to obtain a contract was $0.3 million and $0.4 million , respectively. For the nine months ended September 30, 2019 and 2018 , the amount of amortization related to capitalized costs to obtain a contract was $1.1 million and $1.2 million , respectively. Contract Liabilities Contract liabilities, which are included in deferred revenue on the Company’s condensed consolidated balance sheet, represent the Company’s obligation to transfer service or equipment to a customer for which it has previously received consideration from a customer. As of September 30, 2019 , the total transaction price allocated to unsatisfied (or partially unsatisfied) performance obligations was $33.1 million . The amount of revenue recognized during the nine months ended September 30, 2019 from performance obligations included in the contract liability balance at the beginning of the 2019 period was $29.5 million . The amount of revenue recognized during the nine months ended September 30, 2018 from performance obligations included in the contract liability balance at the beginning of the 2018 period was $27.1 million . In general, the duration of the Company’s contracts is one year or less; however, from time to time, the Company offers multi-year contracts. As of September 30, 2019 , the Company expects to recognize $27.8 million , or approximately 84% , of its remaining performance obligations during the next twelve months and $2.4 million , or approximately 7% , between two to seven years from the balance sheet date. The remaining $2.9 million , or approximately 9% , is related to a single contract and will be recognized as work is performed by the Company, the timing of which is currently unknown.

Leases

Leases	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Leases	3. LEASES Adoption of ASC Topic 842 “Leases” On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method. The Company has presented financial results and applied its accounting policies for the period beginning January 1, 2019 under ASC 842, while prior period results and accounting policies have not been adjusted and are reflected under legacy GAAP pursuant to ASC 840. In connection with the adoption of ASC 842, the Company performed an analysis of contracts under ASC 840 to ensure proper assessment of leases (or embedded leases) in existence as of January 1, 2019. The Company elected the package of practical expedients permitted under ASC 842, which allows the Company not to reassess 1) whether any expired or existing contracts as of the adoption date are or contain a lease, 2) lease classification for any expired or existing leases as of the adoption date and 3) initial direct costs for any existing leases as of the adoption date. The most significant impact of applying ASC 842 was the recognition of right-of-use assets and lease liabilities for operating leases in its condensed consolidated balance sheet. For finance leases, the accounting remained generally consistent with legacy GAAP; however, the existing capital lease and obligation for these leases have been reclassified to a right-of-use asset and lease liability. On January 1, 2019, the Company recognized an initial operating right-of-use asset of $3.3 million and associated operating lease liabilities of $3.7 million . Since adoption of ASC 842 on January 1, 2019, the Company entered into additional leases, most significantly a lease agreement for its new headquarters location (see further discussion in Note 9: Related Party Transactions ), resulting in the recognition of additional right-of-use assets and associated lease liabilities of $14.3 million . There was no impact to opening retained deficit as of January 1, 2019. Leases The Company has operating and finance leases for facilities and equipment throughout the United States and around the world, including corporate offices, satellite control centers, ground control centers, gateways and certain equipment. Upon inception of a contract, the Company evaluates if the contract, or part of the contract, contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Leases include both a right-of-use asset and a lease liability. The right-of-use asset represents the Company’s right to use the underlying asset in the lease. Certain initial direct costs associated with consummating a lease are included in the initial measurement of the right-of-use asset. The right-of-use asset also includes prepaid lease payments and lease incentives. The lease liability represents the present value of the remaining lease payments discounted using the implicit rate in the lease on the lease commencement date. For leases in which the implicit rate is not readily determinable, an estimated incremental borrowing rate is used, which represents a rate of interest that the Company would pay to borrow on a collateralized basis over a similar term. The Company has elected to combine lease and nonlease components, if applicable. As of September 30, 2019 , there are no leases not yet commenced that create significant rights and obligations. For operating leases, the Company records lease expense on a straight-line basis over the lease term in either marketing, general and administrative expense or cost of services, depending on the nature of the underlying asset. For finance leases, the Company records the amortization of the right-of-use asset through depreciation, amortization and accretion expense and records the interest expense on the lease liability through interest expense, net, using the effective interest method. Variable lease payments are payments made to a lessor due to changes in circumstances occurring after the commencement date. Variable lease payments dependent upon an index or rate are included in the measurement of the lease liability; all other variable lease payments are not included in the measurement of the lease liability and recognized when incurred. Variable lease payments excluded from the measurement of the lease liability are uncommon and, when incurred, are immaterial for the Company. The Company’s leases have remaining lease terms of 1 year to 12 years. Lease terms include renewal or termination options that the Company is reasonably certain to exercise. For leases with a term of twelve months or less, the Company does not record a right-of-use asset and associated lease liability on its condensed consolidated balance sheet. The Company reviews the carrying value of its right-of-use assets for impairment whenever events or changes in circumstances indicate that the recorded value may not be recoverable. Recoverability of assets is measured by comparing the carrying amounts of the assets to the estimated future undiscounted cash flows, excluding financing costs. If the Company determines that an impairment exists, any related impairment loss is estimated based on fair values. The following tables disclose the components of the Company’s finance and operating leases (amounts in thousands): As of: September 30, 2019 Operating leases: Right-of-use asset, net $ 16,270 Short-term lease liability (as recorded in accrued expenses) 1,588 Long-term lease liability 15,158 Total operating lease liabilities $ 16,746 Finance leases: Right-of-use asset, net (as recorded in intangible and other current assets, net) $ 121 Short-term lease liability (as recorded in accrued expenses) 77 Long-term lease liability (as recorded in non-current liabilities) 34 Total finance lease liabilities $ 111 Impact on Financial Statements The following table summarizes the impact of the adoption of ASC 842 on the Company’s condensed consolidated balance sheet. There was no impact on the Company’s condensed consolidated statement of operations as a result of this adoption. Amounts are in thousands. Condensed Consolidated Balance Sheet As of September 30, 2019 Impact on change in accounting policy As reported Impact of Legacy Right-of-use asset, net $ 16,270 $ (16,270 ) $ — Intangible and other assets, net 121 (121 ) — Property and equipment, net — 121 121 Accrued expenses 1,665 (1,480 ) 185 Lease liabilities 15,158 (15,158 ) — Other non-current liabilities 34 — 34 Lease Cost The components of lease cost are reflected in the table below (amounts in thousands). As noted above, prior periods have not been adjusted under the modified retrospective method of adoption. Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 Operating lease cost: Amortization of right-of-use assets $ 440 $ 1,257 Interest on lease liabilities 305 747 Finance lease cost: Amortization of right-of-use assets 26 78 Interest on lease liabilities 3 9 Short-term lease cost 3 179 Total lease cost $ 777 $ 2,270 Weighted-Average Remaining Lease Term and Discount Rate The following table discloses the weighted-average remaining lease term and discount rate for finance and operating leases. As of: September 30, 2019 Weighted-average lease term Finance leases 1.6 years Operating Leases 7.6 years Weighted-average discount rate Finance leases 8.0 % Operating leases 7.2 % Supplemental Cash Flow Information The below table discloses supplemental cash flow information for finance and operating leases (in thousands). Nine Months Ended September 30, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,870 Operating cash flows from finance leases 9 Financing cash flows from finance leases 69 Maturity Analysis The following table reflects undiscounted cash flows on an annual basis for the Company’s lease liabilities as of September 30, 2019 (amounts in thousands): Operating Leases Finance Leases 2019 (remaining) $ 774 $ 26 2020 3,029 72 2021 2,456 11 2022 2,342 6 2023 2,370 3 2024 2,370 — Thereafter 11,109 — Total lease payments $ 24,450 $ 118 Imputed interest (7,704 ) (7 ) Discounted lease liability $ 16,746 $ 111
Leases	3. LEASES Adoption of ASC Topic 842 “Leases” On January 1, 2019, the Company adopted ASC 842 using the modified retrospective method. The Company has presented financial results and applied its accounting policies for the period beginning January 1, 2019 under ASC 842, while prior period results and accounting policies have not been adjusted and are reflected under legacy GAAP pursuant to ASC 840. In connection with the adoption of ASC 842, the Company performed an analysis of contracts under ASC 840 to ensure proper assessment of leases (or embedded leases) in existence as of January 1, 2019. The Company elected the package of practical expedients permitted under ASC 842, which allows the Company not to reassess 1) whether any expired or existing contracts as of the adoption date are or contain a lease, 2) lease classification for any expired or existing leases as of the adoption date and 3) initial direct costs for any existing leases as of the adoption date. The most significant impact of applying ASC 842 was the recognition of right-of-use assets and lease liabilities for operating leases in its condensed consolidated balance sheet. For finance leases, the accounting remained generally consistent with legacy GAAP; however, the existing capital lease and obligation for these leases have been reclassified to a right-of-use asset and lease liability. On January 1, 2019, the Company recognized an initial operating right-of-use asset of $3.3 million and associated operating lease liabilities of $3.7 million . Since adoption of ASC 842 on January 1, 2019, the Company entered into additional leases, most significantly a lease agreement for its new headquarters location (see further discussion in Note 9: Related Party Transactions ), resulting in the recognition of additional right-of-use assets and associated lease liabilities of $14.3 million . There was no impact to opening retained deficit as of January 1, 2019. Leases The Company has operating and finance leases for facilities and equipment throughout the United States and around the world, including corporate offices, satellite control centers, ground control centers, gateways and certain equipment. Upon inception of a contract, the Company evaluates if the contract, or part of the contract, contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Leases include both a right-of-use asset and a lease liability. The right-of-use asset represents the Company’s right to use the underlying asset in the lease. Certain initial direct costs associated with consummating a lease are included in the initial measurement of the right-of-use asset. The right-of-use asset also includes prepaid lease payments and lease incentives. The lease liability represents the present value of the remaining lease payments discounted using the implicit rate in the lease on the lease commencement date. For leases in which the implicit rate is not readily determinable, an estimated incremental borrowing rate is used, which represents a rate of interest that the Company would pay to borrow on a collateralized basis over a similar term. The Company has elected to combine lease and nonlease components, if applicable. As of September 30, 2019 , there are no leases not yet commenced that create significant rights and obligations. For operating leases, the Company records lease expense on a straight-line basis over the lease term in either marketing, general and administrative expense or cost of services, depending on the nature of the underlying asset. For finance leases, the Company records the amortization of the right-of-use asset through depreciation, amortization and accretion expense and records the interest expense on the lease liability through interest expense, net, using the effective interest method. Variable lease payments are payments made to a lessor due to changes in circumstances occurring after the commencement date. Variable lease payments dependent upon an index or rate are included in the measurement of the lease liability; all other variable lease payments are not included in the measurement of the lease liability and recognized when incurred. Variable lease payments excluded from the measurement of the lease liability are uncommon and, when incurred, are immaterial for the Company. The Company’s leases have remaining lease terms of 1 year to 12 years. Lease terms include renewal or termination options that the Company is reasonably certain to exercise. For leases with a term of twelve months or less, the Company does not record a right-of-use asset and associated lease liability on its condensed consolidated balance sheet. The Company reviews the carrying value of its right-of-use assets for impairment whenever events or changes in circumstances indicate that the recorded value may not be recoverable. Recoverability of assets is measured by comparing the carrying amounts of the assets to the estimated future undiscounted cash flows, excluding financing costs. If the Company determines that an impairment exists, any related impairment loss is estimated based on fair values. The following tables disclose the components of the Company’s finance and operating leases (amounts in thousands): As of: September 30, 2019 Operating leases: Right-of-use asset, net $ 16,270 Short-term lease liability (as recorded in accrued expenses) 1,588 Long-term lease liability 15,158 Total operating lease liabilities $ 16,746 Finance leases: Right-of-use asset, net (as recorded in intangible and other current assets, net) $ 121 Short-term lease liability (as recorded in accrued expenses) 77 Long-term lease liability (as recorded in non-current liabilities) 34 Total finance lease liabilities $ 111 Impact on Financial Statements The following table summarizes the impact of the adoption of ASC 842 on the Company’s condensed consolidated balance sheet. There was no impact on the Company’s condensed consolidated statement of operations as a result of this adoption. Amounts are in thousands. Condensed Consolidated Balance Sheet As of September 30, 2019 Impact on change in accounting policy As reported Impact of Legacy Right-of-use asset, net $ 16,270 $ (16,270 ) $ — Intangible and other assets, net 121 (121 ) — Property and equipment, net — 121 121 Accrued expenses 1,665 (1,480 ) 185 Lease liabilities 15,158 (15,158 ) — Other non-current liabilities 34 — 34 Lease Cost The components of lease cost are reflected in the table below (amounts in thousands). As noted above, prior periods have not been adjusted under the modified retrospective method of adoption. Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 Operating lease cost: Amortization of right-of-use assets $ 440 $ 1,257 Interest on lease liabilities 305 747 Finance lease cost: Amortization of right-of-use assets 26 78 Interest on lease liabilities 3 9 Short-term lease cost 3 179 Total lease cost $ 777 $ 2,270 Weighted-Average Remaining Lease Term and Discount Rate The following table discloses the weighted-average remaining lease term and discount rate for finance and operating leases. As of: September 30, 2019 Weighted-average lease term Finance leases 1.6 years Operating Leases 7.6 years Weighted-average discount rate Finance leases 8.0 % Operating leases 7.2 % Supplemental Cash Flow Information The below table discloses supplemental cash flow information for finance and operating leases (in thousands). Nine Months Ended September 30, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,870 Operating cash flows from finance leases 9 Financing cash flows from finance leases 69 Maturity Analysis The following table reflects undiscounted cash flows on an annual basis for the Company’s lease liabilities as of September 30, 2019 (amounts in thousands): Operating Leases Finance Leases 2019 (remaining) $ 774 $ 26 2020 3,029 72 2021 2,456 11 2022 2,342 6 2023 2,370 3 2024 2,370 — Thereafter 11,109 — Total lease payments $ 24,450 $ 118 Imputed interest (7,704 ) (7 ) Discounted lease liability $ 16,746 $ 111

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	4. PROPERTY AND EQUIPMENT Property and equipment consists of the following (in thousands): September 30, December 31, Globalstar System: Space component First and second-generation satellites in service $ 1,195,291 $ 1,195,291 Second-generation satellite, on-ground spare 32,443 32,481 Ground component 268,687 256,850 Construction in progress: Ground component 12,614 18,068 Next-generation software upgrades 3,229 2,250 Other 1,277 2,699 Total Globalstar System 1,513,541 1,507,639 Internally developed and purchased software 19,160 26,045 Equipment 10,162 10,097 Land and buildings 3,259 3,311 Leasehold improvements 1,644 1,478 Total property and equipment 1,547,766 1,548,570 Accumulated depreciation (727,451 ) (665,875 ) Total property and equipment, net $ 820,315 $ 882,695 Amounts in the above table consist primarily of costs incurred related to the construction of the Company’s second-generation constellation and ground upgrades. The remaining ground component of construction in progress represents costs (including capitalized interest) incurred for assets to upgrade the Company's ground infrastructure in certain regions around the world. These gateway assets will be deployed based on coverage optimization. In January 2019, the Company completed technology upgrades to allow customers to use Sat-Fi2 ® in certain areas of Latin America. Accordingly, it placed into service approximately $7.9 million of construction in progress (including capitalized interest) related to the deployment of two RANs to this region during 2019. The ground component of construction in progress also includes costs (including capitalized interest) associated with the Company's contract for the procurement and production of new gateway antennas. Additionally, during the first quarter of 2019, a portion of internally developed and purchased software assets were retired, which drove the decrease in the table above. Amounts included in the Company’s second-generation satellite, on-ground spare balance as of September 30, 2019 and December 31, 2018 , consist primarily of costs related to a spare second-generation satellite that has not been placed in orbit, but is capable of being included in a future launch. As of September 30, 2019 , this satellite has not been placed into service; therefore, the Company has not started to record depreciation expense.

Long-Term Debt and Other Financ

Long-Term Debt and Other Financing Arrangements	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Long-Term Debt and Other Financing Arrangements	5. LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS Long-term debt consists of the following (in thousands): September 30, 2019 December 31, 2018 Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Facility Agreement $ 341,955 $ 17,771 $ 324,184 $ 389,390 $ 24,355 $ 365,035 Subordinated Loan Agreement 64,423 110 64,313 — — — Loan Agreement with Thermo 131,046 19,640 111,406 119,702 22,665 97,037 8.00% Convertible Senior Notes Issued in 2013 1,394 — 1,394 1,379 — 1,379 Total Debt 538,818 37,521 501,297 510,471 47,020 463,451 Less: Current Portion 98,829 — 98,829 96,249 — 96,249 Long-Term Debt $ 439,989 $ 37,521 $ 402,468 $ 414,222 $ 47,020 $ 367,202 The principal amounts shown above include payment of in-kind interest, as applicable. The carrying value is net of deferred financing costs and any discounts to the loan amounts at issuance, including accretion, as further described below. The current portion of long-term debt represents the scheduled principal repayments under the Facility Agreement due within one year of the balance sheet date and the total outstanding balance of the Company's 8.00% Convertible Senior Notes Issued in 2013 (the "2013 8.00% Notes") based on the put and call features in these notes. The Company believes that the principal payments due in December 2019 and June 2020 under the Facility Agreement will be in excess of its available sources of cash in order to also maintain compliance with the required balance in the debt service reserve account. The Company is currently negotiating an amendment to these debt obligations; however, the definitive documentation for such amendment has not been executed. Facility Agreement In 2009, the Company entered into the Facility Agreement with a syndicate of bank lenders, including BNP Paribas, Société Générale, Natixis, Crédit Agricole Corporate and Investment Bank (formerly Calyon) and Crédit Industriel et Commercial, as arrangers, and BNP Paribas, as the security agent. The Facility Agreement was amended and restated in July 2013, August 2015 and June 2017. The Facility Agreement is scheduled to mature in December 2022 . As of September 30, 2019 , the Facility Agreement was fully drawn. Semi-annual principal repayments began in December 2014. Indebtedness under the Facility Agreement bears interest at a floating rate of LIBOR plus a margin that increases by 0.5% each year to a maximum rate of LIBOR plus 5.75% . For the twelve-month period ended June 30, 2019, this rate was LIBOR plus 3.75% . This margin increased to 4.25% on July 1, 2019 . Interest on the Facility Agreement is payable semi-annually in arrears on June 30 and December 31 of each calendar year. Ninety-five percent of the Company’s obligations under the Facility Agreement are guaranteed by Bpifrance Assurance Export S.A.S. (“BPIFAE”) (formerly COFACE), the French export credit agency. The Company’s obligations under the Facility Agreement are guaranteed on a senior secured basis by all of its domestic subsidiaries and are secured by a first priority lien on substantially all of the assets of the Company and its domestic subsidiaries (other than their FCC licenses), including patents and trademarks, 100% of the equity of the Company’s domestic subsidiaries and 65% of the equity of certain foreign subsidiaries. The Facility Agreement contains customary events of default and requires that the Company satisfy various financial and non-financial covenants. The covenants in the Facility Agreement limit the Company's ability to, among other things, incur or guarantee additional indebtedness; make certain investments, acquisitions or capital expenditures above certain agreed levels; pay dividends or repurchase or redeem capital stock or subordinated indebtedness; grant liens on its assets; incur restrictions on the ability of its subsidiaries to pay dividends or to make other payments to the Company; enter into transactions with its affiliates; merge or consolidate with other entities or transfer all or substantially all of its assets; and transfer or sell assets. In calculating compliance with the financial covenants of the Facility Agreement, the Company may include certain cash funds contributed to the Company from the issuance of the Company's common stock and/or subordinated indebtedness. These funds are referred to as “Equity Cure Contributions” and may be used to achieve compliance with financial covenants through December 2019. If the Company violates any covenants and is unable to obtain a sufficient Equity Cure Contribution or obtain a waiver, or is unable to make payments to satisfy its debt obligations under the Facility Agreement when due and is unable to obtain a waiver, it would be in default under the Facility Agreement and payment of the indebtedness could be accelerated. The acceleration of the Company's indebtedness under one agreement may permit acceleration of indebtedness under other agreements that contain cross-acceleration provisions. The Company needed an Equity Cure Contribution to maintain compliance with financial covenants under the Facility Agreement for the measurement period ended June 30, 2019, which it obtained through the Subordinated Loan Agreement. The Company anticipates that it will also need an Equity Cure Contribution to maintain compliance with financial covenants for the measurement period ended December 31, 2019, subject to the provisions of the Facility Agreement. The source of funds for this Equity Cure Contribution has not yet been arranged. Additionally, the Company may not be in compliance with financial covenants for the measurement period June 30, 2020, and the Facility Agreement would not permit an Equity Cure Contribution at that time. As discussed above, the Company is actively working to amend the terms of the Facility Agreement, which is expected to include an extension of the Company's ability to use Equity Cure Contributions; however, the terms of any such amendment have not been finalized. As of September 30, 2019 , the Company was in compliance with respect to the covenants of the Facility Agreement, except that the Company and its lenders are currently discussing whether or not the Company was in compliance with certain administrative covenants, including primarily related to treasury processes required within the Accounts Agreement. The Company expects these items will be resolved as part of the amendment that is currently being negotiated. The Facility Agreement also requires the Company to maintain a debt service reserve account, which is pledged to secure all of the Company's obligations under the Facility Agreement. The use of the debt service reserve account funds is restricted to making principal and interest payments under the Facility Agreement. The balance in the debt service reserve account must equal at least the total amount of principal and interest payable by the Company on the next payment date. As of September 30, 2019 , the balance in the debt service reserve account was $59.1 million and the balance in the equity proceeds account, that is also required to be used for obligations under the Facility Agreement, was $2.1 million, both of which are classified as restricted cash on the Company's condensed consolidated balance sheet. In June 2019, the Company and the Lenders under the Facility Agreement reached an agreement in principal, which provides for the amendment of the Facility Agreement. We are currently negotiating the terms of the amendment, which is subject to final definitive documentation and customary closing requirements and conditions. The amendment provides primarily for (i) prepayment of the next three scheduled principal payments primarily using proceeds from a new second lien term loan facility, (ii) revisions to the remaining repayment schedule to reduce the amount of scheduled payments of principal required prior to maturity, and (iii) a reset of financial covenant levels together with an extension of the availability of the cure mechanism under the Facility Agreement. The Company cannot provide assurance that the amendment will be completed or that we will be able to obtain the second lien term loan facility. Subordinated Loan On July 2, 2019, the Company entered into a Subordinated Loan Agreement (the “Subordinated Loan Agreement”), effective as of June 28, 2019, with Thermo Funding Company LLC (an affiliated entity to Thermo), and certain unaffiliated parties (together with Thermo, the “Lenders”). Under the Subordinated Loan Agreement, the Lenders lent $62.0 million to the Company on June 28, 2019 for the primary purpose of funding the June 30, 2019 scheduled payment of interest and principal under the Company’s Facility Agreement and for certain other purposes. The loans under the Subordinated Loan Agreement qualified as an Equity Cure Contribution under the Facility Agreement. Globalstar’s indebtedness to the Lenders is subordinated to all obligations of the Company under the Facility Agreement. Thermo has agreed to subordinate the Company’s obligations to it under the Loan Agreement to the Company’s obligations under the Subordinated Loan Agreement. The Subordinated Loan Agreement accrues interest at 15% per annum, which is capitalized and added to the outstanding principal in lieu of cash payments. Payments to the Lenders will be made only when permitted under the Facility Agreement. The Subordinated Loan Agreement becomes due and payable on December 31, 2023, or upon any acceleration of the maturity of the Subordinated Loan Agreement. As of September 30, 2019 , $2.4 million of interest had accrued with respect to the Subordinated Loan Agreement; the Subordinated Loan Agreement is included in long-term debt on the Company’s condensed consolidated balance sheet. The Subordinated Loan Agreement also contains an affirmative covenant requiring the Company to use reasonable best efforts to either (i) refinance its obligations under the Facility Agreement and the Subordinated Loan Agreement in full or (ii) refinance its obligations under the Subordinated Loan Agreement and obtain a corresponding amendment of the Facility Agreement to permit such refinancing. In addition, in the event the Company’s obligations under the Subordinated Loan Agreement have not been refinanced within 150 days of the date of the Subordinated Loan Agreement, the Company is required to use its reasonable best efforts to issue and do all things to facilitate the issuance of registered warrants exercisable for shares of common stock in the Company to the Lenders in such amounts and on such terms and the Company and the Lenders shall agree. The 150 day deadline noted above is an extension of the original 120 day deadline provided in the Subordinated Loan Agreement. The Company evaluated the affirmative covenant in the Subordinated Loan Agreement and determined that the warrants did not qualify as contingently issuable equity under ASC 815 as of September 30, 2019 because the definitive terms of such warrants were not agreed upon at the time the Subordinated Loan Agreement was executed. The Company’s Board of Directors considered the Subordinated Loan Agreement and the related transactions and unanimously concluded that they constitute a “Permitted Financing” under Article Eleventh of the Second Amended and Restated Certificate of Incorporation of the Company. Thermo Loan Agreement In connection with the amendment and restatement of the Facility Agreement in July 2013, the Company amended and restated its loan agreement with Thermo (the “Loan Agreement”). All obligations of the Company to Thermo under the Loan Agreement are subordinated to the Company’s obligations under the Facility Agreement. The Loan Agreement is convertible into shares of common stock at a conversion price of $0.69 (as adjusted) per share of common stock. Based on the terms of the Settlement Agreement (as defined and discussed further in Note 8: Contingencies ), the outstanding debt under the Loan Agreement with Thermo will convert into shares of Globalstar common stock at the conversion price in place at the time of certain financing events described in the Settlement Agreement, if and when such events occur. The Company expects that Thermo will agree to voluntarily convert the principal balance outstanding under the Thermo Loan Agreement if the amendment to the Facility Agreement discussed above is completed. The Loan Agreement accrues interest at 12% per annum, which is capitalized and added to the outstanding principal in lieu of cash payments. The Company will make payments to Thermo only when permitted by the Facility Agreement. Principal and interest under the Loan Agreement become due and payable six months after the obligations under the Facility Agreement have been paid in full, or earlier if the Company has a change in control or if any acceleration of the maturity of the loans under the Facility Agreement occurs. As of September 30, 2019 , $87.5 million of interest had accrued since 2009 with respect to the Loan Agreement; the Loan Agreement is included in long-term debt on the Company’s condensed consolidated balance sheets. The Company evaluated the various embedded derivatives within the Loan Agreement (See Note 7: Fair Value Measurements for additional information about the embedded derivative in the Loan Agreement). The Company determined that the conversion option and the contingent put feature upon a fundamental change required bifurcation from the Loan Agreement. The conversion option and the contingent put feature were not deemed clearly and closely related to the Loan Agreement and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability on its condensed consolidated balance sheets with a corresponding debt discount, which is netted against the face value of the Loan Agreement. The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the maturity of the Loan Agreement using an effective interest rate method. The fair value of the compound embedded derivative liability is marked-to-market at the end of each reporting period, with any changes in value reported in the condensed consolidated statements of operations. The Company determines the fair value of the compound embedded derivative using a Monte Carlo simulation model. If the principal balance under the Thermo Loan is converted as discussed above, any remaining debt discount and deferred financing costs would be written off through the statement of operations and the derivative liability would be marked-to-market at the conversion date and then extinguished through the statement of operations. As previously disclosed, in connection with the Settlement Agreement discussed in Note 8: Contingencies , the Company formed a Strategic Review Committee that is required to remain in existence for as long as Thermo and its affiliates beneficially own forty-five percent ( 45% ) or more of Globalstar’s outstanding common stock. To the extent permitted by applicable law, the Strategic Review Committee has exclusive responsibility for the oversight, review and approval of, among other things and subject to certain exceptions, any acquisition by Thermo and its affiliates of additional newly-issued securities of the Company and any transaction between the Company and Thermo and its affiliates with a value in excess of $250,000 . The approval of any of the foregoing transactions will require the vote of at least a majority of the Strategic Review Committee. 8.00% Convertible Senior Notes Issued in 2013 The 2013 8.00% Notes are convertible into shares of common stock at a conversion price of $0.69 (as adjusted) per share of common stock. The conversion price of the 2013 8.00% Notes is adjusted in the event of certain stock splits or extraordinary share distributions, or as a reset of the base conversion and exercise price pursuant to the terms of the Fourth Supplemental Indenture between the Company and U.S. Bank National Association, as Trustee, dated May 20, 2013 (the “Indenture”). The 2013 8.00% Notes are senior unsecured debt obligations of the Company with no sinking fund. The 2013 8.00% Notes will mature on April 1, 2028, subject to various call and put features, and bear interest at a rate of 8.00% per annum. Subject to certain conditions set forth in the Indenture, the Company may redeem the 2013 8.00% Notes, with the prior approval of the majority lenders under the Facility Agreement, in whole or in part, at any time on or after April 1, 2018, at a price equal to the principal amount of the 2013 8.00% Notes to be redeemed plus all accrued and unpaid interest thereon. As of September 30, 2019 , the 2013 8.00% Notes have not been redeemed by the Company. A holder of the 2013 8.00% Notes has the right, at the holder’s option, to require the Company to purchase some or all of the 2013 8.00% Notes held by it on April 1, 2023 at a price equal to the principal amount of the 2013 8.00% Notes to be purchased plus accrued and unpaid interest. Interest on the 2013 8.00% Notes is payable semi-annually in arrears on April 1 and October 1 of each year. Interest is paid in cash at a rate of 5.75% per annum and in additional notes at a rate of 2.25% per annum. The Indenture for the 2013 8.00% Notes provides for customary events of default. As of September 30, 2019 , the Company was in compliance with the terms of the 2013 8.00% Notes and the Indenture. Subject to the procedures for conversion and other terms and conditions of the Indenture, a holder may convert its 2013 8.00% Notes at its option at any time prior to the close of business on the business day immediately preceding April 1, 2028 , into shares of common stock (or, at the option of the Company, cash in lieu of all or a portion thereof, provided that, under the Facility Agreement, the Company may pay cash only with the consent of the majority lenders) over a 40 -consecutive trading day settlement period. As of September 30, 2019 , holders had converted a total of $55.4 million principal amount of the 2013 8.00% Notes, resulting in the issuance of approximately 98.5 million shares of voting common stock. The Company evaluated the various embedded derivatives within the Indenture for the 2013 8.00% Notes. The Company determined that the conversion option and the contingent put feature within the Indenture required bifurcation from the 2013 8.00% Notes. The Company recorded this compound embedded derivative liability as a liability on its condensed consolidated balance sheets with a corresponding debt discount which was netted against the face value of the 2013 8.00% Notes. See Note 6: Derivatives for further information.

Derivatives

Derivatives	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	6. DERIVATIVES In connection with certain existing borrowing arrangements, the Company was required to record derivative instruments on its condensed consolidated balance sheets. None of these derivative instruments are designated as a hedge. The following table discloses the fair values of the derivative instruments on the Company’s condensed consolidated balance sheets (in thousands): September 30, 2019 December 31, 2018 Derivative liabilities: Compound embedded derivative with the 2013 8.00% Notes $ (129 ) $ (757 ) Compound embedded derivative with the Loan Agreement with Thermo (4,456 ) (146,108 ) Total derivative liabilities $ (4,585 ) $ (146,865 ) The following table discloses the changes in value recorded as derivative gain (loss) in the Company’s condensed consolidated statement of operations (in thousands): Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Compound embedded derivative with the 2013 8.00% Notes $ 159 $ 322 628 709 Compound embedded derivative with the Loan Agreement with Thermo 49,997 38,737 141,652 145,235 Total derivative gain $ 50,156 $ 39,059 $ 142,280 $ 145,944 Intangible and Other Assets Interest Rate Cap In June 2009, in connection with entering into the Facility Agreement, under which interest accrues at a variable rate, the Company entered into five ten -year interest rate cap agreements, which mature in December 2019. The interest rate cap agreements reflect a variable notional amount at interest rates that provide coverage to the Company for exposure resulting from escalating interest rates over the term of the Facility Agreement. The interest rate cap provides limits on the six-month Libor rate (“Base Rate”) used to calculate the coupon interest on outstanding amounts on the Facility Agreement and is capped at 5.50% should the Base Rate not exceed 6.5% . Should the Base Rate exceed 6.5% , the Company’s Base Rate will be 1% less than the then six-month Libor rate. The Company paid an approximately $12.4 million upfront fee for the interest rate cap agreements. The interest rate cap did not qualify for hedge accounting treatment, and changes in the fair value of the agreements are included in the condensed consolidated statements of operations. The value of the interest rate cap was approximately zero as of September 30, 2019 and December 31, 2018 , respectively. Derivative Liabilities The Company has identified various embedded derivatives resulting from certain features in the Company’s debt instruments, including the conversion option and the contingent put feature within both the 2013 8.00% Notes and the Loan Agreement with Thermo. The fair value of each embedded derivative liability is marked-to-market at the end of each reporting period, or more frequently as deemed necessary, with any changes in value reported in its condensed consolidated statements of operations and its condensed consolidated statements of cash flows as an operating activity. The Company determined the fair value of its compound embedded derivative liabilities using a Monte Carlo simulation model. See Note 7: Fair Value Measurements for further discussion. Consistent with the classification of the 2013 8.00% Notes on the Company's condensed consolidated balance sheet, the Company has classified the associated derivative liability as current on its condensed consolidated balance sheet at September 30, 2019 .

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements	7. FAIR VALUE MEASUREMENTS The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein. This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). Recurring Fair Value Measurements The following tables provide a summary of the liabilities measured at fair value on a recurring basis (in thousands): September 30, 2019 (Level 1) (Level 2) (Level 3) Total Balance Compound embedded derivative with the 2013 8.00% Notes $ — $ — $ (129 ) $ (129 ) Compound embedded derivative with the Loan Agreement with Thermo — — (4,456 ) (4,456 ) Total liabilities measured at fair value $ — $ — $ (4,585 ) $ (4,585 ) December 31, 2018 (Level 1) (Level 2) (Level 3) Total Balance Compound embedded derivative with the 2013 8.00% Notes $ — $ — $ (757 ) $ (757 ) Compound embedded derivative with the Loan Agreement with Thermo — — (146,108 ) (146,108 ) Total liabilities measured at fair value $ — $ — $ (146,865 ) $ (146,865 ) Derivative Liabilities The Company has two derivative liabilities classified as Level 3. The Company marks-to-market these liabilities at each reporting date, or more frequently as deemed necessary, with the changes in fair value recognized in the Company’s condensed consolidated statements of operations. See Note 6: Derivatives for further discussion. The significant quantitative Level 3 inputs utilized in the valuation models are shown in the tables below: September 30, 2019 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 70% - 130% 1.6 % $ 0.69 11% - 27% $ 0.41 Compound embedded derivative with the Loan Agreement with Thermo 70% - 130% 1.6 % $ 0.69 27 % $ 0.41 December 31, 2018 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 40% - 120% 2.5 % $ 0.69 28 % $ 0.64 Compound embedded derivative with the Loan Agreement with Thermo 40% - 120% 2.5 % $ 0.69 28 % $ 0.64 Fluctuation in the Company’s stock price is one of the primary drivers for the changes in the derivative valuations during each reporting period. The Company's stock price decreased 36% from December 31, 2018 to September 30, 2019 . As the stock price decreases, the value to the holder of the instrument generally decreases, thereby decreasing the liability on the Company’s condensed consolidated balance sheets. Stock price volatility is another significant unobservable input used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the expected volatility of the Company's stock price. Decreases in expected volatility would generally result in a lower fair value measurement. Probability of a change of control is another significant unobservable input used in the fair value measurement of the Company’s derivative instruments. Subject to certain restrictions in each indenture, the Company’s debt instruments contain certain provisions whereby holders may require the Company to purchase all or any portion of the convertible debt instrument upon a change of control. A change of control will occur upon certain changes in the ownership of the Company or certain events relating to the trading of the Company’s common stock. The simulated fair value of the derivative liabilities above is sensitive to changes in the assumed probabilities of a change of control. Increases in the assumed probability of a change of control in the short-term would generally result in a lower fair value measurement, while increases in the assumed probability of a change in control in the long-term would generally result in a higher fair value measurement. As previously discussed, the Company is actively working on a refinancing of its debt obligations. A refinancing may result in the conversion of certain outstanding loan agreements. The potential conversion of both the Thermo Loan Agreement and the 2013 8.00% Notes was modeled based on a probability assessment of each financing scenario and, accordingly, was included in the valuation of the associated compound embedded derivatives as of September 30, 2019. These assumptions resulted in a reduction of the derivative valuations during the three and nine months ended September 30, 2019. In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivatives within the Company’s 2013 8.00% Notes and Loan Agreement with Thermo included the following inputs and features: payment-in-kind interest payments, make-whole premiums, a 40 -day stock issuance settlement period upon conversion, estimated maturity date, and the principal balance of each loan at the balance sheet date. There are also certain put and call features, as well as potential redemptions by the Company, within the 2013 8.00% Notes that impact the valuation model. The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Balance at beginning of period $ (54,741 ) $ (121,100 ) $ (146,865 ) $ (227,985 ) Unrealized gain, included in derivative gain 50,156 39,059 142,280 145,944 Balance at end of period $ (4,585 ) $ (82,041 ) $ (4,585 ) $ (82,041 ) Fair Value of Debt Instruments The Company believes it is not practicable to determine the fair value of the Facility Agreement without incurring significant additional costs. Unlike typical long-term debt, interest rates and other terms for the Facility Agreement are not readily available and generally involve a variety of factors, including due diligence by the debt holders. The following table sets forth the carrying values and estimated fair values of the Company's other debt instruments, which are classified as Level 3 financial instruments (in thousands): September 30, 2019 December 31, 2018 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value Loan Agreement with Thermo $ 111,406 $ 83,686 $ 97,037 $ 67,452 2013 8.00% Notes 1,394 837 1,379 734

Contingencies

Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Contingencies	8. CONTINGENCIES Securities Claim On September 25, 2018, a shareholder action was filed against Globalstar, Inc. (the "Company" or "Globalstar"), members of the Board of Directors, Thermo Companies, Inc., and certain members of Globalstar management in the Court of Chancery of the State of Delaware (the "Court"), captioned Mudrick Capital Management, LP, et al. v. Monroe, et al. , C.A. No. 2018-0699-TMR (the "Action"). As previously disclosed, on December 14, 2018, all parties to the Action, including plaintiffs Mudrick Capital Management, L.P. (“Mudrick Capital”) and Warlander Asset Management (“Warlander”, and, together with Mudrick Capital, the “Plaintiffs”), entered into a stipulation and agreement of settlement, compromise and release of stockholder derivative action (the “Settlement Agreement”) to settle all claims asserted against all defendants in the Action. On September 5, 2019, the Court approved the Settlement Agreement and awarded to the Plaintiffs' attorneys a fee of $4.5 million , inclusive of expenses. Payment of the fee award is due after the Court's order and judgment became final in November 2019. As of September 30, 2019 , the Plaintiff's award was not paid, and, accordingly, the Company accrued $4.5 million as a current liability on the its condensed consolidated balance sheet. This settlement award, as well as other costs incurred by the Company directly associated with the Action, exceeded the Company's retention limit of $1.5 million for a "securities claim" under its directors and officers insurance policy. According to ASC 450, a recovery related to a contingent loss (e.g., insurance recovery) is a contingent gain. Recovery of a recorded contingent loss shall be recognized only when realization of the recovery is deemed probable and reasonably estimable. Accordingly, the Company has recorded a receivable of $4.8 million , which includes the $4.5 million settlement fee and certain other costs in excess of the Company's retention, as of September 30, 2019 . The Company expects that this amount will be paid by its primary insurance provider in November 2019. The Company believes it is probable that its remaining costs will also be paid by the Company's insurance provider. This remaining uncollected amount is a contingent gain which would be recognized when realizable. Tariff Ruling In September 2019, U.S Customs and Border Protection ("CBP") issued a ruling related to the classification of certain of the Company's core products imported from China. This classification, which carries 25% tariffs upon import, is inconsistent with the classification the Company previously used based on external legal advice. As a result of the CBP ruling, during the third quarter of 2019, the Company recorded a payable of approximately $1.8 million in accrued expenses on the Company's condensed consolidated balance sheet related to goods imported from China from July 6, 2018 through September 30, 2019. Of the total amount accrued as of September 30, 2019, $0.9 million was associated with inventory sold since July 2018, thereby negatively impacting cost of subscriber equipment sales during the three months ended September 30, 2019. Of the remaining $0.9 million , $0.5 million was recorded as an increase to inventory as the goods have not yet been sold and $0.4 million was recorded as an offsetting receivable because the Company believes this amount, which represents the portion of duties owed for equipment transferred to foreign subsidiaries for sale, is recoverable as a duty drawback. The Company plans on filing a protest against this ruling to challenge the classification and reduce the amounts owed. The Company cannot provide any assurance that it may be successful in achieving a favorable outcome; as such, the Company is accounting for this matter as a gain contingency and may record any such gain from a reimbursement or change in ruling in future periods if and when the contingency is resolved. Business Economic Loss Claim In May 2018, the Company concluded the settlement of a business economic loss claim in which it was an absent member in a tort class action lawsuit. The Company is due proceeds of $7.4 million , net of legal fees, related to this settlement. The Company received the first installment of $3.7 million in January 2019. The final installment of $3.7 million is expected to be received in January 2020 and is recorded in prepaid expenses and other current assets on the Company's condensed consolidated balance sheet at September 30, 2019. The Company evaluated the facts and circumstances surrounding this settlement and determined that under ASC 450, this contingent gain was considered realizable as the signed settlement was enforceable, the counterparty had the wherewithal to pay the amount and the proceeds met the definition of an asset. During the second quarter of 2018, the Company recorded the present value of the proceeds of $6.8 million and a discount of $0.6 million . The present value of the net proceeds of $6.8 million was recorded in other income on the Company's condensed consolidated statement of operations. The discount of $0.6 million was recorded on the Company's condensed consolidated balance sheet and is being accreted to interest income over the term of the receivable using the effective interest method. Other Litigation Due to the nature of the Company's business, the Company is involved, from time to time, in various litigation matters or subject to disputes or routine claims regarding its business activities. Legal costs related to these matters are expensed as incurred. In management's opinion, there is no pending litigation, dispute or claim, other than those described in this report, which could be expected to have a material adverse effect on the Company's financial condition, results of operations or liquidity.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	9. RELATED PARTY TRANSACTIONS Payables to Thermo and other affiliates related to normal purchase transactions were $0.4 million and $0.7 million as of September 30, 2019 and December 31, 2018 , respectively. Transactions with Thermo Certain general and administrative expenses are incurred by Thermo on behalf of the Company. These expenses, which include non-cash expenses that the Company accounts for as a contribution to capital, related to services provided by certain executive officers of Thermo and expenses incurred by Thermo on behalf of the Company which are charged to the Company. The expenses charged are based on actual amounts (with no mark-up) incurred by Thermo or upon allocated employee time. The expenses charged to the Company were $0.1 million and $0.2 million during the three months ended September 30, 2019 and 2018 , respectively, and $0.3 million and $0.6 million during the nine months ended September 30, 2019 and 2018 , respectively. Additionally, in February 2019, the Company entered into a lease agreement with Thermo Covington, LLC for the Company's new headquarters office. Annual lease payments for the new location will be $1.4 million per year, increasing at a rate of 2.5% per year, for a lease term of ten years. During the three and nine months ended September 30, 2019 , the Company incurred lease expense of $0.5 million and $1.3 million due to Thermo under this lease agreement. As of September 30, 2019 , the principal amount outstanding under the Loan Agreement with Thermo was $131.0 million , and the fair value of the compound embedded derivative liability associated with the Loan Agreement was $4.5 million . During the three months ended September 30, 2019 and 2018 , interest accrued on the Loan Agreement was approximately $3.9 million and $3.5 million , respectively. During the nine months ended September 30, 2019 and 2018 , interest accrued on the Loan Agreement was approximately $11.3 million and $10.0 million , respectively. On July 2, 2019, the Company entered into a Subordinated Loan Agreement, effective June 28, 2019, with Thermo and certain unaffiliated parties. Thermo's participation in the Subordinated Loan Agreement was $53.8 million . As of September 30, 2019 , $2.1 million of interest had accrued with respect to Thermo's portion of the Subordinated Loan Agreement. On April 24, 2018, Globalstar entered into the Merger Agreement with GBS Acquisitions, Inc., a Delaware corporation and wholly owned subsidiary of Globalstar (“Merger Sub”), Thermo Acquisitions, Inc., a Delaware corporation (“Thermo Acquisitions”), the stockholders of Thermo Acquisitions (collectively, the “Thermo Stockholders,” and each, individually, a “Thermo Stockholder”), and Thermo Development, Inc., in its capacity as the representative of the Thermo Stockholders as set forth therein (the “Stockholders’ Representative”). Thermo Acquisitions is controlled by James Monroe III, Executive Chairman of the Board of Directors of Globalstar and former Chief Executive Officer of Globalstar. Pursuant to the terms of the Merger Agreement, Merger Sub would merge with and into Thermo Acquisitions with Thermo Acquisitions continuing as the surviving corporation and a wholly owned subsidiary of Globalstar (the “Merger”). The transaction was unanimously recommended by the Special Committee of the Board of Directors of Globalstar, consisting entirely of disinterested independent directors, and unanimously approved by the full Board of Directors. On July 31, 2018, Globalstar, following the unanimous recommendation of its Special Committee of independent directors, and the Stockholders’ Representative, terminated the Merger Agreement by mutual written agreement by entering into a Termination of Agreement and Plan of Merger, between Globalstar and the Stockholders’ Representative. In addition, on July 31, 2018, the Voting Agreement between Globalstar and certain of its stockholders terminated in accordance with its terms as a result of the termination of the Merger Agreement. No termination fees are payable in connection with the termination of the Merger Agreement. As previously disclosed, in connection with the Settlement Agreement discussed in Note 8: Contingencies , the Company formed a Strategic Review Committee that is required to remain in existence for as long as Thermo and its affiliates beneficially own forty-five percent ( 45% ) or more of Globalstar’s outstanding common stock. To the extent permitted by applicable law, the Strategic Review Committee will have exclusive responsibility for the oversight, review and approval of, among other things and subject to certain exceptions, any acquisition by Thermo and its affiliates of additional newly-issued securities of the Company and any transaction between the Company and Thermo and its affiliates with a value in excess of $250,000 . The approval of any of the foregoing transactions will require the vote of at least a majority of the Strategic Review Committee. See Note 5: Long-Term Debt and Other Financing Arrangements for further discussion of the Company's debt and financing transactions with Thermo.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	10. EARNINGS (LOSS) PER SHARE Basic earnings (loss) per share is computed by dividing income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. The numerator includes the effect of dilutive securities, including interest expense, net, and derivative gains or losses reflected in net income (loss). During the third quarter of 2019, the Company identified a misapplication of GAAP in the previously reported calculation of net income (loss) attributable to common stockholders in the numerator of diluted EPS for certain prior periods. The correction of this calculation had no impact on net income (loss), retained deficit or any other financial statement line items. For comparative purposes, prior period calculations of diluted EPS have been adjusted to conform to current period presentation. Common stock equivalents are included in the calculation of diluted earnings per share only when the effect of their inclusion would be dilutive. Potentially dilutive securities include primarily outstanding stock-based awards, convertible notes and shares issuable pursuant to the Company's Employee Stock Purchase Plan. The share amounts for dilutive securities that are reflected in the table below are shown regardless of being in or out of the money. The following table sets forth the calculation of basic and diluted earnings (loss) per share and reconciles basic weighted average shares to diluted weighted average shares of common stock outstanding for the periods indicated (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Net income $ 21,111 $ 9,019 $ 53,071 $ 89,937 Effect of dilutive securities: 2013 8.00% Notes (132 ) (294 ) (548 ) (643 ) Loan Agreement with Thermo (45,205 ) (34,350 ) (127,743 ) (134,979 ) Loss to common stockholders plus assumed conversions $ (24,226 ) $ (25,625 ) $ (75,220 ) $ (45,685 ) Weighted average common shares outstanding: Basic shares outstanding 1,451,703 1,264,516 1,450,146 1,263,416 Incremental shares from assumed exercises, conversions and other issuance of: Stock options, restricted stock, restricted stock units and ESPP 4,089 2,370 5,179 5,661 2013 8.00% Notes 2,021 1,867 2,021 2,087 Loan Agreement with Thermo 189,921 159,047 189,921 177,756 Diluted shares outstanding 1,647,734 1,427,800 1,647,267 1,448,920 Net income (loss) per share: Basic $ 0.01 $ 0.01 $ 0.04 $ 0.07 Diluted (0.01 ) (0.02 ) (0.05 ) (0.03 )

Condensed Consolidating Financi

Condensed Consolidating Financial Information	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Financial Information	11. CONDENSED CONSOLIDATING FINANCIAL INFORMATION In connection with the Company’s issuance of the 2013 8.00% Notes, certain of the Company’s 100% owned domestic subsidiaries (the “Guarantor Subsidiaries”), fully, unconditionally, jointly, and severally guaranteed the payment obligations under the 2013 8.00% Notes. The following financial information sets forth, on a consolidating basis, the balance sheets, statements of operations and statements of cash flows for Globalstar, Inc. (the “Parent Company”), for the Guarantor Subsidiaries and for the Parent Company’s other subsidiaries (the “Non-Guarantor Subsidiaries”). The condensed consolidating financial information has been prepared pursuant to the rules and regulations for condensed financial information and does not include disclosures included in annual financial statements. The principal eliminating entries eliminate investments in subsidiaries, intercompany balances and intercompany revenues and expenses. Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended September 30, 2019 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenue $ 21,493 $ 13,173 $ 19,767 $ (20,281 ) $ 34,152 Subscriber equipment sales 462 4,354 1,678 (2,032 ) 4,462 Total revenue 21,955 17,527 21,445 (22,313 ) 38,614 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 6,555 1,645 2,238 (1,222 ) 9,216 Cost of subscriber equipment sales 217 4,890 1,406 (2,031 ) 4,482 Marketing, general and administrative 8,522 1,371 22,063 (19,061 ) 12,895 Depreciation, amortization and accretion 23,371 17 638 — 24,026 Total operating expenses 38,665 7,923 26,345 (22,314 ) 50,619 Income (loss) from operations (16,710 ) 9,604 (4,900 ) 1 (12,005 ) Other income (expense): Interest income and expense, net of amounts capitalized (14,445 ) (5 ) (21 ) — (14,471 ) Derivative gain 50,156 — — — 50,156 Equity in subsidiary earnings (loss) 2,761 (3,427 ) — 666 — Other (651 ) 200 (2,075 ) (3 ) (2,529 ) Total other income (expense) 37,821 (3,232 ) (2,096 ) 663 33,156 Income (loss) before income taxes 21,111 6,372 (6,996 ) 664 21,151 Income tax expense — 7 33 — 40 Net income (loss) $ 21,111 $ 6,365 $ (7,029 ) $ 664 $ 21,111 Comprehensive income (loss) $ 21,111 $ 6,365 $ (6,017 ) $ 674 $ 22,133 Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended September 30, 2018 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenue $ 22,750 $ 11,627 $ 16,915 $ (21,394 ) $ 29,898 Subscriber equipment sales 260 5,144 1,695 (1,305 ) 5,794 Total revenue 23,010 16,771 18,610 (22,699 ) 35,692 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 6,825 1,556 2,429 (1,381 ) 9,429 Cost of subscriber equipment sales 176 4,259 1,297 (1,306 ) 4,426 Marketing, general and administrative 10,706 1,468 22,911 (20,024 ) 15,061 Depreciation, amortization and accretion 25,041 52 (355 ) — 24,738 Total operating expenses 42,748 7,335 26,282 (22,711 ) 53,654 Income (loss) from operations (19,738 ) 9,436 (7,672 ) 12 (17,962 ) Other income (expense): Interest income and expense, net of amounts capitalized (13,360 ) (5 ) 7 — (13,358 ) Derivative gain 39,059 — — — 39,059 Equity in subsidiary earnings (loss) 3,170 (2,571 ) — (599 ) — Other (112 ) 23 1,431 (11 ) 1,331 Total other income (expense) 28,757 (2,553 ) 1,438 (610 ) 27,032 Income (loss) before income taxes 9,019 6,883 (6,234 ) (598 ) 9,070 Income tax expense — 5 46 — 51 Net income (loss) $ 9,019 $ 6,878 $ (6,280 ) $ (598 ) $ 9,019 Comprehensive income (loss) $ 9,019 $ 6,878 $ (5,906 ) $ (472 ) $ 9,519 Globalstar, Inc. Condensed Consolidating Statement of Operations Nine Months Ended September 30, 2019 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenue $ 66,485 $ 32,067 $ 50,880 $ (62,461 ) $ 86,971 Subscriber equipment sales 1,163 11,592 4,754 (4,597 ) 12,912 Total revenue 67,648 43,659 55,634 (67,058 ) 99,883 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 20,571 4,472 7,325 (3,904 ) 28,464 Cost of subscriber equipment sales 708 11,282 3,813 (4,594 ) 11,209 Marketing, general and administrative 22,297 3,928 67,861 (58,563 ) 35,523 Depreciation, amortization and accretion 69,721 20 1,938 — 71,679 Total operating expenses 113,297 19,702 80,937 (67,061 ) 146,875 Income (loss) from operations (45,649 ) 23,957 (25,303 ) 3 (46,992 ) Other income (expense): Interest income and expense, net of amounts capitalized (40,101 ) (12 ) (36 ) — (40,149 ) Derivative gain 142,280 — — — 142,280 Gain on legal settlement 120 — — — 120 Equity in subsidiary earnings (loss) (2,452 ) (12,050 ) — 14,502 — Other (1,127 ) 327 (1,258 ) (6 ) (2,064 ) Total other income (expense) 98,720 (11,735 ) (1,294 ) 14,496 100,187 Income (loss) before income taxes 53,071 12,222 (26,597 ) 14,499 53,195 Income tax expense — 33 91 — 124 Net income (loss) $ 53,071 $ 12,189 $ (26,688 ) $ 14,499 $ 53,071 Comprehensive income (loss) $ 53,071 $ 12,189 $ (26,436 ) $ 14,501 $ 53,325 Globalstar, Inc. Condensed Consolidating Statement of Operations Nine Months Ended September 30, 2018 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenue $ 66,554 $ 30,993 $ 48,929 $ (62,573 ) $ 83,903 Subscriber equipment sales 511 12,541 4,266 (3,054 ) 14,264 Total revenue 67,065 43,534 53,195 (65,627 ) 98,167 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 19,827 4,444 7,591 (3,878 ) 27,984 Cost of subscriber equipment sales 382 10,350 3,091 (3,055 ) 10,768 Marketing, general and administrative 29,173 3,989 67,852 (58,734 ) 42,280 Revision to contract termination charge (20,478 ) — — — (20,478 ) Depreciation, amortization and accretion 65,434 216 935 — 66,585 Total operating expenses 94,338 18,999 79,469 (65,667 ) 127,139 Income (loss) from operations (27,273 ) 24,535 (26,274 ) 40 (28,972 ) Other income (expense): Interest income and expense, net of amounts capitalized (31,081 ) (9 ) 24 50 (31,016 ) Derivative gain 145,944 — — — 145,944 Gain on legal settlement 6,779 — — — 6,779 Equity in subsidiary earnings (loss) (3,950 ) (12,199 ) — 16,149 — Other (482 ) 140 (2,302 ) (38 ) (2,682 ) Total other income (expense) 117,210 (12,068 ) (2,278 ) 16,161 119,025 Income (loss) before income taxes 89,937 12,467 (28,552 ) 16,201 90,053 Income tax expense — 21 95 — 116 Net income (loss) $ 89,937 $ 12,446 $ (28,647 ) $ 16,201 $ 89,937 Comprehensive (loss) income $ 89,937 $ 12,446 $ (25,945 ) $ 16,299 $ 92,737 Globalstar, Inc. Condensed Consolidating Balance Sheet As of September 30, 2019 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 22,238 $ 159 $ 3,828 $ — $ 26,225 Restricted cash 61,224 — — — 61,224 Accounts receivable, net of allowance 7,067 8,697 5,145 — 20,909 Intercompany receivables 1,085,038 860,279 90,528 (2,035,845 ) — Inventory 6,061 9,023 2,156 — 17,240 Prepaid expenses and other current assets 11,269 6,423 3,224 — 20,916 Total current assets 1,192,897 884,581 104,881 (2,035,845 ) 146,514 Property and equipment, net 790,615 1,105 28,591 4 820,315 Operating lease right of use assets, net 11,965 217 4,088 — 16,270 Intercompany notes receivable 5,674 — — (5,674 ) — Investment in subsidiaries (249,110 ) 42,618 57,472 149,020 — Intangible and other assets, net 31,583 246 4,927 (12 ) 36,744 Total assets $ 1,783,624 $ 928,767 $ 199,959 $ (1,892,507 ) $ 1,019,843 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 98,829 $ — $ — $ — $ 98,829 Accounts payable 1,683 2,393 943 — 5,019 Accrued expenses 19,953 9,699 7,187 — 36,839 Intercompany payables 816,507 849,900 369,380 (2,035,787 ) — Payables to affiliates 353 — — — 353 Derivative liabilities 129 — — — 129 Deferred revenue 1,669 20,673 5,497 — 27,839 Total current liabilities 939,123 882,665 383,007 (2,035,787 ) 169,008 Long-term debt, less current portion 402,468 — — — 402,468 Operating lease liabilities 11,602 182 3,374 — 15,158 Employee benefit obligations 4,619 — — — 4,619 Intercompany notes payable — — 5,674 (5,674 ) — Derivative liabilities 4,456 — — — 4,456 Deferred revenue 5,080 158 23 — 5,261 Other non-current liabilities 134 322 2,275 — 2,731 Total non-current liabilities 428,359 662 11,346 (5,674 ) 434,693 Stockholders’ equity (deficit) 416,142 45,440 (194,394 ) 148,954 416,142 Total liabilities and stockholders’ equity $ 1,783,624 $ 928,767 $ 199,959 $ (1,892,507 ) $ 1,019,843 Globalstar, Inc. Condensed Consolidating Balance Sheet As of December 31, 2018 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 11,312 $ 2,126 $ 1,774 $ — $ 15,212 Restricted cash 60,278 — — — 60,278 Accounts receivable, net of allowance 7,138 7,826 4,363 — 19,327 Intercompany receivables 1,047,320 824,920 105,819 (1,978,059 ) — Inventory 6,747 6,149 1,378 — 14,274 Prepaid expenses and other current assets 7,765 2,987 2,658 — 13,410 Total current assets 1,140,560 844,008 115,992 (1,978,059 ) 122,501 Property and equipment, net 850,790 1,242 30,658 5 882,695 Intercompany notes receivable 5,600 — 6,436 (12,036 ) — Investment in subsidiaries (255,187 ) 42,481 50,220 162,486 — Intangible and other assets, net 36,275 324 3,698 (11 ) 40,286 Total assets $ 1,778,038 $ 888,055 $ 207,004 $ (1,827,615 ) $ 1,045,482 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 96,249 $ — $ — $ — $ 96,249 Accounts payable 2,420 3,378 1,197 — 6,995 Accrued expenses 8,904 6,747 7,434 — 23,085 Intercompany payables 778,340 832,284 367,396 (1,978,020 ) — Payables to affiliates 656 — — — 656 Derivative liabilities 757 — — — 757 Deferred revenue 1,699 23,943 6,296 — 31,938 Total current liabilities 889,025 866,352 382,323 (1,978,020 ) 159,680 Long-term debt, less current portion 367,202 — — — 367,202 Employee benefit obligations 4,489 — — — 4,489 Intercompany notes payable 6,436 — 5,600 (12,036 ) — Derivative liabilities 146,108 — — — 146,108 Deferred revenue 5,339 335 18 — 5,692 Other non-current liabilities 494 323 2,549 — 3,366 Total non-current liabilities 530,068 658 8,167 (12,036 ) 526,857 Stockholders’ equity (deficit) 358,945 21,045 (183,486 ) 162,441 358,945 Total liabilities and stockholders’ equity $ 1,778,038 $ 888,055 $ 207,004 $ (1,827,615 ) $ 1,045,482 Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Nine Months Ended September 30, 2019 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by (used in) operating activities $ 4,521 $ (1,659 ) $ 3,182 $ — $ 6,044 Cash flows provided by (used in) investing activities: Second-generation network costs (including interest) (1,309 ) — (41 ) — (1,350 ) Property and equipment additions (3,068 ) (308 ) (104 ) — (3,480 ) Investment in business 155 — — — 155 Purchase of intangible assets (1,993 ) — (957 ) — (2,950 ) Net cash used in investing activities (6,215 ) (308 ) (1,102 ) — (7,625 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (47,435 ) — — — (47,435 ) Payments for financing costs (1,401 ) — — — (1,401 ) Proceeds from Subordinated Loan Agreement 62,000 — — — 62,000 Proceeds from issuance of common stock and exercise of options and warrants 402 — — — 402 Net cash provided by financing activities 13,566 — — — 13,566 Effect of exchange rate changes on cash, cash equivalents and restricted cash — — (26 ) — (26 ) Net increase (decrease) in cash, cash equivalents and restricted cash 11,872 (1,967 ) 2,054 — 11,959 Cash, cash equivalents and restricted cash, beginning of period 71,590 2,126 1,774 — 75,490 Cash, cash equivalents and restricted cash, end of period $ 83,462 $ 159 $ 3,828 $ — $ 87,449 Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Nine Months Ended September 30, 2018 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by (used in) operating activities $ 11,458 $ 7,412 $ 898 $ — $ 19,768 Cash flows used in investing activities: Second-generation network costs (including interest) (4,629 ) — (1,258 ) — (5,887 ) Property and equipment additions (4,140 ) (900 ) (306 ) — (5,346 ) Purchase of intangible assets (1,904 ) — (44 ) — (1,948 ) Net cash used in investing activities (10,673 ) (900 ) (1,608 ) — (13,181 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (38,933 ) — — — (38,933 ) Proceeds from issuance of common stock and exercise of options and warrants 395 — — — 395 Net cash used in financing activities (38,538 ) — — — (38,538 ) Effect of exchange rate changes on cash, cash equivalents and restricted cash — — 68 — 68 Net decrease in cash, cash equivalents and restricted cash (37,753 ) 6,512 (642 ) — (31,883 ) Cash, cash equivalents and restricted cash, beginning of period 96,499 4,942 3,838 — 105,279 Cash, cash equivalents and restricted cash, end of period $ 58,746 $ 11,454 $ 3,196 $ — $ 73,396

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Globalstar, Inc. (“Globalstar” or the “Company”) provides Mobile Satellite Services (“MSS”) including voice and data communications services through its global satellite network. Thermo Companies, through commonly controlled affiliates, (collectively, “Thermo”), is the principal owner and largest stockholder of Globalstar. The Company’s Executive Chairman of the Board controls Thermo. Two other members of the Company's Board of Directors are also directors, officers or minority equity owners of various Thermo entities. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information. Certain information and footnote disclosures normally in financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”); however, management believes the disclosures made are adequate to make the information presented not misleading. These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Globalstar Annual Report on Form 10-K for the year ended December 31, 2018 , as filed with the SEC on February 28, 2019 (the “ 2018 Annual Report”), and Management's Discussion and Analysis of Financial Condition and Results of Operations herein. The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from estimates. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation and income taxes. The Company has made certain reclassifications to prior period condensed consolidated financial statements to conform to current period presentation. These unaudited interim condensed consolidated financial statements include the accounts of Globalstar and all its subsidiaries. All significant intercompany transactions and balances have been eliminated in the consolidation. In the opinion of management, the information included herein includes all adjustments, consisting of normal recurring adjustments, that are necessary for a fair presentation of the Company’s condensed consolidated statements of operations, condensed consolidated balance sheets, condensed consolidated statements of stockholders' equity and condensed consolidated statements of cash flows for the periods presented. The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the full year or any future period.
Recently Issued and Adopted Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) No. 2016-13, Credit Losses, Measurement of Credit Losses on Financial Instruments . ASU No. 2016-13, as amended, significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard will replace today’s incurred loss approach with an expected loss model for instruments measured at amortized cost. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted for all entities for annual periods beginning after December 15, 2018, and interim periods therein. The Company has not yet determined the impact this standard will have on its financial statements and related disclosures. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement . As part of the FASB's disclosure framework project, it has eliminated, amended and added disclosure requirements for fair value measurements. Entities will no longer be required to disclose the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy, the policy of timing of transfers between levels of the fair value hierarchy and the valuation processes for Level 3 fair value measurements. Public companies will be required to disclose the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of any interim or annual reporting period. This ASU will have an impact on the Company's disclosures. In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans . As part of the FASB's disclosure framework project, it has changed the disclosure requirements for defined pension and other post-retirement benefit plans. The FASB eliminated disclosure requirements related to the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year, the amount and timing of plan assets expected to be returned to the employer, if any, information related to Japanese Welfare Pension Insurance Law, information about the amount of future annual benefits covered by insurance contracts and significant transactions between the employer or related parties and the plan, and the disclosure of the effects of a one-percentage-point change in the assumed health care cost trend rates on the (1) aggregate of the service and interest cost components of net periodic benefit costs and the (2) benefit obligation for postretirement health care benefits. Entities will be required to disclose the weighted-average interest crediting rate for cash balance plans and other plans with promised interest crediting rates as well as an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. This ASU is effective for public entities for annual periods beginning after December 15, 2020. Early adoption is permitted as of the beginning of any annual reporting period. This ASU will have an impact on the Company's disclosures. In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . This ASU requires companies to defer specified implementation costs in a cloud computing arrangement that are often expensed under current US GAAP and recognize these costs to expense over the noncancellable term of the arrangement. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's financial statements and related disclosures. Recently Issued Financial Reporting Rules In April 2019, the SEC adopted the final rules under SEC Releases 33-10618 and 34-85381, FAST Act Modernization and Simplification of Regulation S-K. Among other things, the amendments 1) allow registrants who present financial statements covering three years in their periodic reports to omit discussion of the earliest year from management's discussion and analysis if the discussion was included in a prior filing, 2) allow registrants to omit certain information and exhibits from their periodic reports without submitting confidential treatment requests to the Commission, 3) clarify and streamline certain risk factor and property disclosure requirements, 4) require all filings to include hyperlinks to information that is incorporated by reference in current filings to the information available on EDGAR, as applicable, and 5) require registrants to apply XBRL tags to certain information on cover pages of SEC filings. Certain of the amended rules became effective April 2, 2019 or May 2, 2019 and have been applied to any filings after these dates, except for the XBRL tagging requirement, which is effective for large accelerated and accelerated filers for fiscal reports ending on or after June 15, 2019 and 2020, respectively. The Company does not expect these final rules to have a material impact on its disclosures and financial statements. Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases . ASU 2016-02 became effective for annual reporting periods beginning after December 15, 2018. ASU 2016-02 amended the FASB Accounting Standards Codification (“ASC”) and created a new ASC Topic 842, “Leases” (“ASC 842”). The Company adopted this standard on January 1, 2019. See Note 3: Leases for further discussion, including the impact on the Company's condensed consolidated financial statements and required disclosures. In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income . This guidance allows companies to reclassify items in accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the H.R.1, “An Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018” (the “Tax Act”) (previously known as “The Tax Cuts and Jobs Act”). This ASU is effective for all entities for annual and interim periods beginning after December 15, 2018. The Company adopted this standard on January 1, 2019. The adoption of this standard did not have a material effect on the Company's financial statements or related disclosures. In June 2018, the FASB issued ASU No. 2018-07, Compensation - Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting . ASU 2018-07 aligns the accounting for share-based payment awards issued to employees and nonemployees. Measurement of equity-classified nonemployee awards will now be valued on the grant date and will no longer be remeasured through the performance completion date. This amendment also changes the accounting for nonemployee awards with performance conditions to recognize compensation cost when achievement of the performance condition is probable, rather than upon achievement of the performance condition, as well as eliminating the requirement to reassess the equity or liability classification for nonemployee awards upon vesting, except for certain award types. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2018. The Company adopted this standard on January 1, 2019. The adoption of this standard did not have a material effect on the Company's financial statements or related disclosures.
Derivative Liabilities	The Company has identified various embedded derivatives resulting from certain features in the Company’s debt instruments, including the conversion option and the contingent put feature within both the 2013 8.00% Notes and the Loan Agreement with Thermo. The fair value of each embedded derivative liability is marked-to-market at the end of each reporting period, or more frequently as deemed necessary, with any changes in value reported in its condensed consolidated statements of operations and its condensed consolidated statements of cash flows as an operating activity. The Company determined the fair value of its compound embedded derivative liabilities using a Monte Carlo simulation model.
Fair Value Measurements	The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein. This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
Earnings (Loss) Per Share	Basic earnings (loss) per share is computed by dividing income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding during the period. The numerator includes the effect of dilutive securities, including interest expense, net, and derivative gains or losses reflected in net income (loss). During the third quarter of 2019, the Company identified a misapplication of GAAP in the previously reported calculation of net income (loss) attributable to common stockholders in the numerator of diluted EPS for certain prior periods. The correction of this calculation had no impact on net income (loss), retained deficit or any other financial statement line items. For comparative purposes, prior period calculations of diluted EPS have been adjusted to conform to current period presentation. Common stock equivalents are included in the calculation of diluted earnings per share only when the effect of their inclusion would be dilutive.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Schedule of revenue disaggregated by product and services	The following table discloses revenue disaggregated by geographical market (amounts in thousands): Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Service revenue: United States $ 23,155 $ 21,096 $ 61,859 $ 59,581 Canada 7,914 5,723 16,057 15,003 Europe 2,251 2,462 6,585 7,113 Central and South America 680 527 1,814 1,708 Others 152 90 656 498 Total service revenue 34,152 29,898 86,971 83,903 Subscriber equipment sales: United States $ 2,435 $ 4,148 $ 7,195 $ 9,202 Canada 1,290 907 3,236 2,050 Europe 371 326 1,388 1,755 Central and South America 345 370 1,006 1,096 Others 21 43 87 161 Total subscriber equipment sales 4,462 5,794 12,912 14,264 Total revenue $ 38,614 $ 35,692 $ 99,883 $ 98,167 The following table discloses revenue disaggregated by type of product and service (amounts in thousands): Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Service revenue: Duplex $ 16,589 $ 12,213 $ 34,265 $ 31,130 SPOT 12,482 12,957 38,196 39,787 Commercial IoT 4,526 3,542 12,577 9,847 IGO 139 257 484 682 Other 416 929 1,449 2,457 Total service revenue 34,152 29,898 86,971 83,903 Subscriber equipment sales: Duplex $ 349 $ 436 $ 906 $ 1,618 SPOT 1,880 2,970 5,657 6,455 Commercial IoT 2,182 2,356 6,226 6,067 Other 51 32 123 124 Total subscriber equipment sales 4,462 5,794 12,912 14,264 Total revenue $ 38,614 $ 35,692 $ 99,883 $ 98,167
Schedule of information related to contracts with customers	The following table discloses information about accounts receivable, costs to obtain a contract (as recorded in intangible and other assets, net on the Company's condensed consolidated balance sheet), and contract liabilities (as recorded in both current and long-term deferred revenue on the Company's condensed consolidated balance sheet) from contracts with customers (amounts in thousands): September 30, 2019 December 31, 2018 Accounts receivable $ 20,909 $ 19,327 Capitalized costs to obtain a contract 1,974 2,018 Contract liabilities 33,100 37,630

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Schedule of lease assets and liabilities	The following tables disclose the components of the Company’s finance and operating leases (amounts in thousands): As of: September 30, 2019 Operating leases: Right-of-use asset, net $ 16,270 Short-term lease liability (as recorded in accrued expenses) 1,588 Long-term lease liability 15,158 Total operating lease liabilities $ 16,746 Finance leases: Right-of-use asset, net (as recorded in intangible and other current assets, net) $ 121 Short-term lease liability (as recorded in accrued expenses) 77 Long-term lease liability (as recorded in non-current liabilities) 34 Total finance lease liabilities $ 111 The following table summarizes the impact of the adoption of ASC 842 on the Company’s condensed consolidated balance sheet. There was no impact on the Company’s condensed consolidated statement of operations as a result of this adoption. Amounts are in thousands. Condensed Consolidated Balance Sheet As of September 30, 2019 Impact on change in accounting policy As reported Impact of Legacy Right-of-use asset, net $ 16,270 $ (16,270 ) $ — Intangible and other assets, net 121 (121 ) — Property and equipment, net — 121 121 Accrued expenses 1,665 (1,480 ) 185 Lease liabilities 15,158 (15,158 ) — Other non-current liabilities 34 — 34
Schedule of components of lease cost	The below table discloses supplemental cash flow information for finance and operating leases (in thousands). Nine Months Ended September 30, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,870 Operating cash flows from finance leases 9 Financing cash flows from finance leases 69 The following table discloses the weighted-average remaining lease term and discount rate for finance and operating leases. As of: September 30, 2019 Weighted-average lease term Finance leases 1.6 years Operating Leases 7.6 years Weighted-average discount rate Finance leases 8.0 % Operating leases 7.2 % The components of lease cost are reflected in the table below (amounts in thousands). As noted above, prior periods have not been adjusted under the modified retrospective method of adoption. Three Months Ended Nine Months Ended September 30, 2019 September 30, 2019 Operating lease cost: Amortization of right-of-use assets $ 440 $ 1,257 Interest on lease liabilities 305 747 Finance lease cost: Amortization of right-of-use assets 26 78 Interest on lease liabilities 3 9 Short-term lease cost 3 179 Total lease cost $ 777 $ 2,270
Schedule of maturities of operating leases liabilities	The following table reflects undiscounted cash flows on an annual basis for the Company’s lease liabilities as of September 30, 2019 (amounts in thousands): Operating Leases Finance Leases 2019 (remaining) $ 774 $ 26 2020 3,029 72 2021 2,456 11 2022 2,342 6 2023 2,370 3 2024 2,370 — Thereafter 11,109 — Total lease payments $ 24,450 $ 118 Imputed interest (7,704 ) (7 ) Discounted lease liability $ 16,746 $ 111
Schedule of maturities of finance leases liabilities	The following table reflects undiscounted cash flows on an annual basis for the Company’s lease liabilities as of September 30, 2019 (amounts in thousands): Operating Leases Finance Leases 2019 (remaining) $ 774 $ 26 2020 3,029 72 2021 2,456 11 2022 2,342 6 2023 2,370 3 2024 2,370 — Thereafter 11,109 — Total lease payments $ 24,450 $ 118 Imputed interest (7,704 ) (7 ) Discounted lease liability $ 16,746 $ 111

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Property and equipment consists of the following (in thousands): September 30, December 31, Globalstar System: Space component First and second-generation satellites in service $ 1,195,291 $ 1,195,291 Second-generation satellite, on-ground spare 32,443 32,481 Ground component 268,687 256,850 Construction in progress: Ground component 12,614 18,068 Next-generation software upgrades 3,229 2,250 Other 1,277 2,699 Total Globalstar System 1,513,541 1,507,639 Internally developed and purchased software 19,160 26,045 Equipment 10,162 10,097 Land and buildings 3,259 3,311 Leasehold improvements 1,644 1,478 Total property and equipment 1,547,766 1,548,570 Accumulated depreciation (727,451 ) (665,875 ) Total property and equipment, net $ 820,315 $ 882,695

Long-Term Debt and Other Fina_2

Long-Term Debt and Other Financing Arrangements (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Schedule of long-term debt	Long-term debt consists of the following (in thousands): September 30, 2019 December 31, 2018 Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Facility Agreement $ 341,955 $ 17,771 $ 324,184 $ 389,390 $ 24,355 $ 365,035 Subordinated Loan Agreement 64,423 110 64,313 — — — Loan Agreement with Thermo 131,046 19,640 111,406 119,702 22,665 97,037 8.00% Convertible Senior Notes Issued in 2013 1,394 — 1,394 1,379 — 1,379 Total Debt 538,818 37,521 501,297 510,471 47,020 463,451 Less: Current Portion 98,829 — 98,829 96,249 — 96,249 Long-Term Debt $ 439,989 $ 37,521 $ 402,468 $ 414,222 $ 47,020 $ 367,202

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair values of derivative instruments	The following table discloses the fair values of the derivative instruments on the Company’s condensed consolidated balance sheets (in thousands): September 30, 2019 December 31, 2018 Derivative liabilities: Compound embedded derivative with the 2013 8.00% Notes $ (129 ) $ (757 ) Compound embedded derivative with the Loan Agreement with Thermo (4,456 ) (146,108 ) Total derivative liabilities $ (4,585 ) $ (146,865 )
Schedule of derivative gains (losses)	The following table discloses the changes in value recorded as derivative gain (loss) in the Company’s condensed consolidated statement of operations (in thousands): Three Months Ended Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Compound embedded derivative with the 2013 8.00% Notes $ 159 $ 322 628 709 Compound embedded derivative with the Loan Agreement with Thermo 49,997 38,737 141,652 145,235 Total derivative gain $ 50,156 $ 39,059 $ 142,280 $ 145,944

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Schedule of financial liabilities measured at fair value on recurring basis	The following tables provide a summary of the liabilities measured at fair value on a recurring basis (in thousands): September 30, 2019 (Level 1) (Level 2) (Level 3) Total Balance Compound embedded derivative with the 2013 8.00% Notes $ — $ — $ (129 ) $ (129 ) Compound embedded derivative with the Loan Agreement with Thermo — — (4,456 ) (4,456 ) Total liabilities measured at fair value $ — $ — $ (4,585 ) $ (4,585 ) December 31, 2018 (Level 1) (Level 2) (Level 3) Total Balance Compound embedded derivative with the 2013 8.00% Notes $ — $ — $ (757 ) $ (757 ) Compound embedded derivative with the Loan Agreement with Thermo — — (146,108 ) (146,108 ) Total liabilities measured at fair value $ — $ — $ (146,865 ) $ (146,865 )
Schedule of significant quantitative Level 3 inputs utilized	The significant quantitative Level 3 inputs utilized in the valuation models are shown in the tables below: September 30, 2019 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 70% - 130% 1.6 % $ 0.69 11% - 27% $ 0.41 Compound embedded derivative with the Loan Agreement with Thermo 70% - 130% 1.6 % $ 0.69 27 % $ 0.41 December 31, 2018 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 40% - 120% 2.5 % $ 0.69 28 % $ 0.64 Compound embedded derivative with the Loan Agreement with Thermo 40% - 120% 2.5 % $ 0.69 28 % $ 0.64
Schedule of rollforward of liabilities measured at fair value	The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Balance at beginning of period $ (54,741 ) $ (121,100 ) $ (146,865 ) $ (227,985 ) Unrealized gain, included in derivative gain 50,156 39,059 142,280 145,944 Balance at end of period $ (4,585 ) $ (82,041 ) $ (4,585 ) $ (82,041 )
Schedule of carrying values and estimated fair values of debt instruments	The following table sets forth the carrying values and estimated fair values of the Company's other debt instruments, which are classified as Level 3 financial instruments (in thousands): September 30, 2019 December 31, 2018 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value Loan Agreement with Thermo $ 111,406 $ 83,686 $ 97,037 $ 67,452 2013 8.00% Notes 1,394 837 1,379 734

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Schedule of reconciliation of basic weighted average share to diluted weighted average common shares outstanding	The following table sets forth the calculation of basic and diluted earnings (loss) per share and reconciles basic weighted average shares to diluted weighted average shares of common stock outstanding for the periods indicated (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Net income $ 21,111 $ 9,019 $ 53,071 $ 89,937 Effect of dilutive securities: 2013 8.00% Notes (132 ) (294 ) (548 ) (643 ) Loan Agreement with Thermo (45,205 ) (34,350 ) (127,743 ) (134,979 ) Loss to common stockholders plus assumed conversions $ (24,226 ) $ (25,625 ) $ (75,220 ) $ (45,685 ) Weighted average common shares outstanding: Basic shares outstanding 1,451,703 1,264,516 1,450,146 1,263,416 Incremental shares from assumed exercises, conversions and other issuance of: Stock options, restricted stock, restricted stock units and ESPP 4,089 2,370 5,179 5,661 2013 8.00% Notes 2,021 1,867 2,021 2,087 Loan Agreement with Thermo 189,921 159,047 189,921 177,756 Diluted shares outstanding 1,647,734 1,427,800 1,647,267 1,448,920 Net income (loss) per share: Basic $ 0.01 $ 0.01 $ 0.04 $ 0.07 Diluted (0.01 ) (0.02 ) (0.05 ) (0.03 )

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information (Tables)	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of condensed consolidating statement of operations	The condensed consolidating financial information has been prepared pursuant to the rules and regulations for condensed financial information and does not include disclosures included in annual financial statements. The principal eliminating entries eliminate investments in subsidiaries, intercompany balances and intercompany revenues and expenses. Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended September 30, 2019 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenue $ 21,493 $ 13,173 $ 19,767 $ (20,281 ) $ 34,152 Subscriber equipment sales 462 4,354 1,678 (2,032 ) 4,462 Total revenue 21,955 17,527 21,445 (22,313 ) 38,614 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 6,555 1,645 2,238 (1,222 ) 9,216 Cost of subscriber equipment sales 217 4,890 1,406 (2,031 ) 4,482 Marketing, general and administrative 8,522 1,371 22,063 (19,061 ) 12,895 Depreciation, amortization and accretion 23,371 17 638 — 24,026 Total operating expenses 38,665 7,923 26,345 (22,314 ) 50,619 Income (loss) from operations (16,710 ) 9,604 (4,900 ) 1 (12,005 ) Other income (expense): Interest income and expense, net of amounts capitalized (14,445 ) (5 ) (21 ) — (14,471 ) Derivative gain 50,156 — — — 50,156 Equity in subsidiary earnings (loss) 2,761 (3,427 ) — 666 — Other (651 ) 200 (2,075 ) (3 ) (2,529 ) Total other income (expense) 37,821 (3,232 ) (2,096 ) 663 33,156 Income (loss) before income taxes 21,111 6,372 (6,996 ) 664 21,151 Income tax expense — 7 33 — 40 Net income (loss) $ 21,111 $ 6,365 $ (7,029 ) $ 664 $ 21,111 Comprehensive income (loss) $ 21,111 $ 6,365 $ (6,017 ) $ 674 $ 22,133 Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended September 30, 2018 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenue $ 22,750 $ 11,627 $ 16,915 $ (21,394 ) $ 29,898 Subscriber equipment sales 260 5,144 1,695 (1,305 ) 5,794 Total revenue 23,010 16,771 18,610 (22,699 ) 35,692 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 6,825 1,556 2,429 (1,381 ) 9,429 Cost of subscriber equipment sales 176 4,259 1,297 (1,306 ) 4,426 Marketing, general and administrative 10,706 1,468 22,911 (20,024 ) 15,061 Depreciation, amortization and accretion 25,041 52 (355 ) — 24,738 Total operating expenses 42,748 7,335 26,282 (22,711 ) 53,654 Income (loss) from operations (19,738 ) 9,436 (7,672 ) 12 (17,962 ) Other income (expense): Interest income and expense, net of amounts capitalized (13,360 ) (5 ) 7 — (13,358 ) Derivative gain 39,059 — — — 39,059 Equity in subsidiary earnings (loss) 3,170 (2,571 ) — (599 ) — Other (112 ) 23 1,431 (11 ) 1,331 Total other income (expense) 28,757 (2,553 ) 1,438 (610 ) 27,032 Income (loss) before income taxes 9,019 6,883 (6,234 ) (598 ) 9,070 Income tax expense — 5 46 — 51 Net income (loss) $ 9,019 $ 6,878 $ (6,280 ) $ (598 ) $ 9,019 Comprehensive income (loss) $ 9,019 $ 6,878 $ (5,906 ) $ (472 ) $ 9,519 Globalstar, Inc. Condensed Consolidating Statement of Operations Nine Months Ended September 30, 2019 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenue $ 66,485 $ 32,067 $ 50,880 $ (62,461 ) $ 86,971 Subscriber equipment sales 1,163 11,592 4,754 (4,597 ) 12,912 Total revenue 67,648 43,659 55,634 (67,058 ) 99,883 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 20,571 4,472 7,325 (3,904 ) 28,464 Cost of subscriber equipment sales 708 11,282 3,813 (4,594 ) 11,209 Marketing, general and administrative 22,297 3,928 67,861 (58,563 ) 35,523 Depreciation, amortization and accretion 69,721 20 1,938 — 71,679 Total operating expenses 113,297 19,702 80,937 (67,061 ) 146,875 Income (loss) from operations (45,649 ) 23,957 (25,303 ) 3 (46,992 ) Other income (expense): Interest income and expense, net of amounts capitalized (40,101 ) (12 ) (36 ) — (40,149 ) Derivative gain 142,280 — — — 142,280 Gain on legal settlement 120 — — — 120 Equity in subsidiary earnings (loss) (2,452 ) (12,050 ) — 14,502 — Other (1,127 ) 327 (1,258 ) (6 ) (2,064 ) Total other income (expense) 98,720 (11,735 ) (1,294 ) 14,496 100,187 Income (loss) before income taxes 53,071 12,222 (26,597 ) 14,499 53,195 Income tax expense — 33 91 — 124 Net income (loss) $ 53,071 $ 12,189 $ (26,688 ) $ 14,499 $ 53,071 Comprehensive income (loss) $ 53,071 $ 12,189 $ (26,436 ) $ 14,501 $ 53,325 Globalstar, Inc. Condensed Consolidating Statement of Operations Nine Months Ended September 30, 2018 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenue $ 66,554 $ 30,993 $ 48,929 $ (62,573 ) $ 83,903 Subscriber equipment sales 511 12,541 4,266 (3,054 ) 14,264 Total revenue 67,065 43,534 53,195 (65,627 ) 98,167 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 19,827 4,444 7,591 (3,878 ) 27,984 Cost of subscriber equipment sales 382 10,350 3,091 (3,055 ) 10,768 Marketing, general and administrative 29,173 3,989 67,852 (58,734 ) 42,280 Revision to contract termination charge (20,478 ) — — — (20,478 ) Depreciation, amortization and accretion 65,434 216 935 — 66,585 Total operating expenses 94,338 18,999 79,469 (65,667 ) 127,139 Income (loss) from operations (27,273 ) 24,535 (26,274 ) 40 (28,972 ) Other income (expense): Interest income and expense, net of amounts capitalized (31,081 ) (9 ) 24 50 (31,016 ) Derivative gain 145,944 — — — 145,944 Gain on legal settlement 6,779 — — — 6,779 Equity in subsidiary earnings (loss) (3,950 ) (12,199 ) — 16,149 — Other (482 ) 140 (2,302 ) (38 ) (2,682 ) Total other income (expense) 117,210 (12,068 ) (2,278 ) 16,161 119,025 Income (loss) before income taxes 89,937 12,467 (28,552 ) 16,201 90,053 Income tax expense — 21 95 — 116 Net income (loss) $ 89,937 $ 12,446 $ (28,647 ) $ 16,201 $ 89,937 Comprehensive (loss) income $ 89,937 $ 12,446 $ (25,945 ) $ 16,299 $ 92,737
Schedule of condensed consolidating balance sheet	Globalstar, Inc. Condensed Consolidating Balance Sheet As of September 30, 2019 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 22,238 $ 159 $ 3,828 $ — $ 26,225 Restricted cash 61,224 — — — 61,224 Accounts receivable, net of allowance 7,067 8,697 5,145 — 20,909 Intercompany receivables 1,085,038 860,279 90,528 (2,035,845 ) — Inventory 6,061 9,023 2,156 — 17,240 Prepaid expenses and other current assets 11,269 6,423 3,224 — 20,916 Total current assets 1,192,897 884,581 104,881 (2,035,845 ) 146,514 Property and equipment, net 790,615 1,105 28,591 4 820,315 Operating lease right of use assets, net 11,965 217 4,088 — 16,270 Intercompany notes receivable 5,674 — — (5,674 ) — Investment in subsidiaries (249,110 ) 42,618 57,472 149,020 — Intangible and other assets, net 31,583 246 4,927 (12 ) 36,744 Total assets $ 1,783,624 $ 928,767 $ 199,959 $ (1,892,507 ) $ 1,019,843 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 98,829 $ — $ — $ — $ 98,829 Accounts payable 1,683 2,393 943 — 5,019 Accrued expenses 19,953 9,699 7,187 — 36,839 Intercompany payables 816,507 849,900 369,380 (2,035,787 ) — Payables to affiliates 353 — — — 353 Derivative liabilities 129 — — — 129 Deferred revenue 1,669 20,673 5,497 — 27,839 Total current liabilities 939,123 882,665 383,007 (2,035,787 ) 169,008 Long-term debt, less current portion 402,468 — — — 402,468 Operating lease liabilities 11,602 182 3,374 — 15,158 Employee benefit obligations 4,619 — — — 4,619 Intercompany notes payable — — 5,674 (5,674 ) — Derivative liabilities 4,456 — — — 4,456 Deferred revenue 5,080 158 23 — 5,261 Other non-current liabilities 134 322 2,275 — 2,731 Total non-current liabilities 428,359 662 11,346 (5,674 ) 434,693 Stockholders’ equity (deficit) 416,142 45,440 (194,394 ) 148,954 416,142 Total liabilities and stockholders’ equity $ 1,783,624 $ 928,767 $ 199,959 $ (1,892,507 ) $ 1,019,843 Globalstar, Inc. Condensed Consolidating Balance Sheet As of December 31, 2018 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 11,312 $ 2,126 $ 1,774 $ — $ 15,212 Restricted cash 60,278 — — — 60,278 Accounts receivable, net of allowance 7,138 7,826 4,363 — 19,327 Intercompany receivables 1,047,320 824,920 105,819 (1,978,059 ) — Inventory 6,747 6,149 1,378 — 14,274 Prepaid expenses and other current assets 7,765 2,987 2,658 — 13,410 Total current assets 1,140,560 844,008 115,992 (1,978,059 ) 122,501 Property and equipment, net 850,790 1,242 30,658 5 882,695 Intercompany notes receivable 5,600 — 6,436 (12,036 ) — Investment in subsidiaries (255,187 ) 42,481 50,220 162,486 — Intangible and other assets, net 36,275 324 3,698 (11 ) 40,286 Total assets $ 1,778,038 $ 888,055 $ 207,004 $ (1,827,615 ) $ 1,045,482 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 96,249 $ — $ — $ — $ 96,249 Accounts payable 2,420 3,378 1,197 — 6,995 Accrued expenses 8,904 6,747 7,434 — 23,085 Intercompany payables 778,340 832,284 367,396 (1,978,020 ) — Payables to affiliates 656 — — — 656 Derivative liabilities 757 — — — 757 Deferred revenue 1,699 23,943 6,296 — 31,938 Total current liabilities 889,025 866,352 382,323 (1,978,020 ) 159,680 Long-term debt, less current portion 367,202 — — — 367,202 Employee benefit obligations 4,489 — — — 4,489 Intercompany notes payable 6,436 — 5,600 (12,036 ) — Derivative liabilities 146,108 — — — 146,108 Deferred revenue 5,339 335 18 — 5,692 Other non-current liabilities 494 323 2,549 — 3,366 Total non-current liabilities 530,068 658 8,167 (12,036 ) 526,857 Stockholders’ equity (deficit) 358,945 21,045 (183,486 ) 162,441 358,945 Total liabilities and stockholders’ equity $ 1,778,038 $ 888,055 $ 207,004 $ (1,827,615 ) $ 1,045,482
Schedule of condensed consolidating statement of cash flows	Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Nine Months Ended September 30, 2019 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by (used in) operating activities $ 4,521 $ (1,659 ) $ 3,182 $ — $ 6,044 Cash flows provided by (used in) investing activities: Second-generation network costs (including interest) (1,309 ) — (41 ) — (1,350 ) Property and equipment additions (3,068 ) (308 ) (104 ) — (3,480 ) Investment in business 155 — — — 155 Purchase of intangible assets (1,993 ) — (957 ) — (2,950 ) Net cash used in investing activities (6,215 ) (308 ) (1,102 ) — (7,625 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (47,435 ) — — — (47,435 ) Payments for financing costs (1,401 ) — — — (1,401 ) Proceeds from Subordinated Loan Agreement 62,000 — — — 62,000 Proceeds from issuance of common stock and exercise of options and warrants 402 — — — 402 Net cash provided by financing activities 13,566 — — — 13,566 Effect of exchange rate changes on cash, cash equivalents and restricted cash — — (26 ) — (26 ) Net increase (decrease) in cash, cash equivalents and restricted cash 11,872 (1,967 ) 2,054 — 11,959 Cash, cash equivalents and restricted cash, beginning of period 71,590 2,126 1,774 — 75,490 Cash, cash equivalents and restricted cash, end of period $ 83,462 $ 159 $ 3,828 $ — $ 87,449 Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Nine Months Ended September 30, 2018 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by (used in) operating activities $ 11,458 $ 7,412 $ 898 $ — $ 19,768 Cash flows used in investing activities: Second-generation network costs (including interest) (4,629 ) — (1,258 ) — (5,887 ) Property and equipment additions (4,140 ) (900 ) (306 ) — (5,346 ) Purchase of intangible assets (1,904 ) — (44 ) — (1,948 ) Net cash used in investing activities (10,673 ) (900 ) (1,608 ) — (13,181 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (38,933 ) — — — (38,933 ) Proceeds from issuance of common stock and exercise of options and warrants 395 — — — 395 Net cash used in financing activities (38,538 ) — — — (38,538 ) Effect of exchange rate changes on cash, cash equivalents and restricted cash — — 68 — 68 Net decrease in cash, cash equivalents and restricted cash (37,753 ) 6,512 (642 ) — (31,883 ) Cash, cash equivalents and restricted cash, beginning of period 96,499 4,942 3,838 — 105,279 Cash, cash equivalents and restricted cash, end of period $ 58,746 $ 11,454 $ 3,196 $ — $ 73,396

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Revenue	$ 38,614	$ 35,692	$ 99,883	$ 98,167
Service revenue:
Disaggregation of Revenue [Line Items]
Revenue	34,152	29,898	86,971	83,903
Service revenue: | United States
Disaggregation of Revenue [Line Items]
Revenue	23,155	21,096	61,859	59,581
Service revenue: | Canada
Disaggregation of Revenue [Line Items]
Revenue	7,914	5,723	16,057	15,003
Service revenue: | Europe
Disaggregation of Revenue [Line Items]
Revenue	2,251	2,462	6,585	7,113
Service revenue: | Central and South America
Disaggregation of Revenue [Line Items]
Revenue	680	527	1,814	1,708
Service revenue: | Others
Disaggregation of Revenue [Line Items]
Revenue	152	90	656	498
Duplex
Disaggregation of Revenue [Line Items]
Revenue	16,589	12,213	34,265	31,130
SPOT
Disaggregation of Revenue [Line Items]
Revenue	12,482	12,957	38,196	39,787
Commercial IoT
Disaggregation of Revenue [Line Items]
Revenue	4,526	3,542	12,577	9,847
IGO
Disaggregation of Revenue [Line Items]
Revenue	139	257	484	682
Other
Disaggregation of Revenue [Line Items]
Revenue	416	929	1,449	2,457
Subscriber equipment sales:
Disaggregation of Revenue [Line Items]
Revenue	4,462	5,794	12,912	14,264
Subscriber equipment sales: | United States
Disaggregation of Revenue [Line Items]
Revenue	2,435	4,148	7,195	9,202
Subscriber equipment sales: | Canada
Disaggregation of Revenue [Line Items]
Revenue	1,290	907	3,236	2,050
Subscriber equipment sales: | Europe
Disaggregation of Revenue [Line Items]
Revenue	371	326	1,388	1,755
Subscriber equipment sales: | Central and South America
Disaggregation of Revenue [Line Items]
Revenue	345	370	1,006	1,096
Subscriber equipment sales: | Others
Disaggregation of Revenue [Line Items]
Revenue	21	43	87	161
Duplex
Disaggregation of Revenue [Line Items]
Revenue	349	436	906	1,618
SPOT
Disaggregation of Revenue [Line Items]
Revenue	1,880	2,970	5,657	6,455
Commercial IoT
Disaggregation of Revenue [Line Items]
Revenue	2,182	2,356	6,226	6,067
Other
Disaggregation of Revenue [Line Items]
Revenue	$ 51	$ 32	$ 123	$ 124

Revenue - Contract Balances (De

Revenue - Contract Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Accounts receivable	$ 20,909	$ 19,327
Capitalized costs to obtain a contract	1,974	2,018
Contract liabilities	$ 33,100	$ 37,630

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue adjustment	$ 38,614	$ 35,692	$ 99,883	$ 98,167
Contract assets	1,600		1,600		$ 700
Accounts receivable	20,909		20,909		19,327
Contract with customer, impairment losses on receivables	$ 1,000	400	$ 3,700	2,200
Capitalized contract cost, amortization period	3 years		3 years
Capitalized contract cost, amortization on previously capitalized costs	$ 300	$ 400	$ 1,100	1,200
Contract liabilities	33,100		33,100		37,630
Contract with customer, revenue recognized			29,500	$ 27,100
IGO
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Accounts receivable	6,000		$ 6,000		$ 7,800
Accounting Standards Update 2014-09
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue adjustment	$ 3,900

Revenue - Remaining Performance

Revenue - Remaining Performance Obligation (Details) $ in Millions	Sep. 30, 2019USD ($)
Revenue from Contract with Customer [Abstract]
Revenue remaining performance obligation, percentage	9.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-07-01
Revenue from Contract with Customer [Abstract]
Revenue remaining performance obligation, percentage	84.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-07-01
Revenue from Contract with Customer [Abstract]
Revenue remaining performance obligation, percentage	7.00%
Long-term | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-07-01
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation, amount	$ 27.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Long-term | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-07-01
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation, amount	$ 2.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	6 years
Short-term
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation, amount	$ 2.9
Short-term | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period

Revenue - Remaining Performan_2

Revenue - Remaining Performance Obligation, Differing Contracts (Details) $ in Millions	Sep. 30, 2019USD ($)
Long-term | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 27.8
Long-term | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	2.4
Short-term
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2.9

Revenue - Remaining Performan_3

Revenue - Remaining Performance Obligation, Differing Contracts (2) (Details) $ in Millions	Sep. 30, 2019USD ($)
Short-term
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 2.9

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($)	Jan. 01, 2019	Sep. 30, 2019	Dec. 31, 2018
Lessee, Lease, Description [Line Items]
Operating lease right of use assets, net		$ 16,270,000	$ 0
Operating lease liabilities		$ 16,746,000
Right-of-use asset obtained in exchange for operating lease liability	$ 14,300,000
Minimum
Lessee, Lease, Description [Line Items]
Lease term (in years)		1 year
Maximum
Lessee, Lease, Description [Line Items]
Lease term (in years)		12 years
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease right of use assets, net	3,300,000	$ 16,270,000
Operating lease liabilities	3,700,000
Impact of adoption of ASC 842 on retained earnings	$ 0

Leases - Components of Finance

Leases - Components of Finance and Operating Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Operating leases:
Right-of-use asset, net	$ 16,270	$ 0
Short-term lease liability (as recorded in accrued expenses)	1,588
Long-term lease liability	15,158	$ 0
Total operating lease liabilities	16,746
Finance leases:
Right-of-use asset, net (as recorded in intangible and other current assets, net)	121
Short-term lease liability (as recorded in accrued expenses)	77
Long-term lease liability (as recorded in non-current liabilities)	34
Total finance lease liabilities	$ 111

Leases - Impact on Financial St

Leases - Impact on Financial Statements (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jan. 01, 2019	Dec. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset, net	$ 16,270		$ 0
Intangible and other assets, net	36,744		40,286
Property and equipment, net	820,315		882,695
Accrued expenses	36,839		23,085
Lease liabilities	15,158		0
Other non-current liabilities	2,731		$ 3,366
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset, net	16,270	$ 3,300
Intangible and other assets, net	121
Property and equipment, net	0
Accrued expenses	1,665
Lease liabilities	15,158
Other non-current liabilities	34
Impact of ASC 842 | Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset, net	(16,270)
Intangible and other assets, net	(121)
Property and equipment, net	121
Accrued expenses	(1,480)
Lease liabilities	(15,158)
Other non-current liabilities	0
Legacy GAAP
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset, net	0
Intangible and other assets, net	0
Property and equipment, net	121
Accrued expenses	185
Lease liabilities	0
Other non-current liabilities	$ 34

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Operating lease cost:
Amortization of right-of-use assets	$ 440	$ 1,257
Interest on lease liabilities	305	747
Finance lease cost:
Amortization of right-of-use assets	26	78
Interest on lease liabilities	3	9
Short-term lease cost	3	179
Total lease cost	$ 777	$ 2,270

Leases - Supplemental Lease Inf

Leases - Supplemental Lease Information (Details)	Sep. 30, 2019
Leases [Abstract]
Weighted-average lease term, Finance leases	1 year 7 months
Weighted-average lease term, Operating leases	7 years 7 months
Weighted-average discount rate, Finance leases	8.00%
Weighted-average discount rate, Operating leases	7.20%

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 1,870
Operating cash flows from finance leases	9
Financing cash flows from finance leases	$ 69

Leases - Maturity Analysis (Det

Leases - Maturity Analysis (Details) $ in Thousands	Sep. 30, 2019USD ($)
Operating Leases
2019 (remaining)	$ 774
2020	3,029
2021	2,456
2022	2,342
2023	2,370
2024	2,370
Thereafter	11,109
Total lease payments	24,450
Imputed interest	(7,704)
Discounted lease liability	16,746
Finance Leases
2019 (remaining)	26
2020	72
2021	11
2022	6
2023	3
2024	0
Thereafter	0
Total lease payments	118
Imputed interest	(7)
Discounted lease liability	$ 111

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	1 Months Ended
	Jan. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 1,547,766	$ 1,548,570
Accumulated depreciation		(727,451)	(665,875)
Total property and equipment, net		820,315	882,695
Internally developed and purchased software
Property, Plant and Equipment [Line Items]
Property and equipment, gross		19,160	26,045
Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross		10,162	10,097
Land and buildings
Property, Plant and Equipment [Line Items]
Property and equipment, gross		3,259	3,311
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross		1,644	1,478
Globalstar System
Property, Plant and Equipment [Line Items]
Property and equipment, gross		1,513,541	1,507,639
Globalstar System | Ground component
Property, Plant and Equipment [Line Items]
Property and equipment, gross		268,687	256,850
Globalstar System | First and second-generation satellites in service | Space component
Property, Plant and Equipment [Line Items]
Property and equipment, gross		1,195,291	1,195,291
Globalstar System | Second-generation satellite, on-ground spare | Space component
Property, Plant and Equipment [Line Items]
Property and equipment, gross		32,443	32,481
Globalstar System | Construction in progress | Ground component
Property, Plant and Equipment [Line Items]
Property and equipment, gross		12,614	18,068
Globalstar System | Construction in progress | Next-generation software upgrades
Property, Plant and Equipment [Line Items]
Property and equipment, gross		3,229	2,250
Globalstar System | Construction in progress | Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 1,277	$ 2,699
Sat-Fi2
Property, Plant and Equipment [Line Items]
Construction in progress placed into service	$ 7,900

Long-Term Debt and Other Fina_3

Long-Term Debt and Other Financing Arrangements - Schedule of Long-term Debt (Details) - USD ($)	Sep. 30, 2019	Jun. 28, 2019	Dec. 31, 2018	Dec. 31, 2013	May 20, 2013
Principal Amount
Total Debt	$ 538,818,000		$ 510,471,000
Less: Current Portion	98,829,000		96,249,000
Long-Term Debt	439,989,000		414,222,000
Unamortized Discount and Deferred Financing Costs
Total Debt	37,521,000		47,020,000
Less: Current Portion	0		0
Long-Term Debt	37,521,000		47,020,000
Carrying Value
Total Debt	501,297,000		463,451,000
Less: Current Portion	98,829,000		96,249,000
Long-Term Debt	402,468,000		367,202,000
Facility Agreement
Principal Amount
Total Debt	341,955,000		389,390,000
Unamortized Discount and Deferred Financing Costs
Total Debt	17,771,000		24,355,000
Carrying Value
Total Debt	324,184,000		365,035,000
Subordinated Loan Agreement
Principal Amount
Total Debt	64,423,000		0
Unamortized Discount and Deferred Financing Costs
Total Debt	110,000		0
Carrying Value
Total Debt	64,313,000		0
Loan Agreement with Thermo
Debt Instrument [Line Items]
Loan interest rate, percentage		15.00%
Principal Amount
Total Debt	131,046,000	$ 62,000,000	119,702,000
Unamortized Discount and Deferred Financing Costs
Total Debt	19,640,000		22,665,000
Carrying Value
Total Debt	$ 111,406,000		97,037,000
8.00% Convertible Senior Notes Issued in 2013
Debt Instrument [Line Items]
Loan interest rate, percentage	8.00%			8.00%	8.00%
Principal Amount
Total Debt	$ 1,394,000		1,379,000
Unamortized Discount and Deferred Financing Costs
Total Debt	0		0
Carrying Value
Total Debt	$ 1,394,000		$ 1,379,000

Long-Term Debt and Other Fina_4

Long-Term Debt and Other Financing Arrangements - Facility Agreement (Details) - Facility Agreement - USD ($) $ in Millions	Jul. 01, 2019	Sep. 30, 2019	Jun. 30, 2019
Debt Instrument [Line Items]
Interest above LIBOR rate, percentage	4.25%		3.75%
Percentage of guarantee provided by French export credit agency to lending syndicate		95.00%
Debt service reserve account		$ 59.1
Balance in the equity proceeds accounts		$ 2.1
Domestic Subsidiaries
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		100.00%
Foreign Subsidiaries
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		65.00%
Minimum
Debt Instrument [Line Items]
Interest rate increase, percentage		0.50%
Maximum
Debt Instrument [Line Items]
Interest rate increase, percentage		5.75%

Long-Term Debt and Other Fina_5

Long-Term Debt and Other Financing Arrangements Long-Term Debt and Other Financing Arrangements - Bridge Loan (Details) - USD ($)	Sep. 30, 2019	Jun. 28, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Subordinated loan agreement, amount	$ 538,818,000		$ 510,471,000
Subordinated Debt
Debt Instrument [Line Items]
Subordinated loan agreement, amount	131,046,000	$ 62,000,000	$ 119,702,000
Loan interest rate, percentage		15.00%
Outstanding interest	$ 2,400,000

Long-Term Debt and Other Fina_6

Long-Term Debt and Other Financing Arrangements - Thermo Loan Agreement (Details)	9 Months Ended
	Sep. 30, 2019USD ($)$ / shares	Jun. 28, 2019
Loan Agreement with Thermo
Debt Instrument [Line Items]
Loan interest rate, percentage		15.00%
Outstanding interest	$ 2,400,000
Loan Agreement with Thermo | Thermo
Debt Instrument [Line Items]
Loan agreement, conversion price (USD per share) | $ / shares	$ 0.69
Loan interest rate, percentage	12.00%
Maturity period after full payment of Facility Agreement	6 months
Outstanding interest	$ 87,500,000
Thermo
Debt Instrument [Line Items]
Equity method investment, threshold percentage requiring a Strategic Review Committee	0.45
Equity method investment, transaction threshold for approval requirement	$ 250,000

Long-Term Debt and Other Fina_7

Long-Term Debt and Other Financing Arrangements - 8.00% Convertible Senior Notes Issued in 2013 (Details) - 8.00% Convertible Senior Notes Issued in 2013 $ / shares in Units, shares in Millions, $ in Millions	69 Months Ended
	Sep. 30, 2019USD ($)dayshares	Dec. 31, 2013$ / shares	May 20, 2013
Debt Instrument [Line Items]
Loan interest rate, percentage	8.00%	8.00%	8.00%
Loan agreement, conversion price (USD per share) | $ / shares		$ 0.69
Interest rate, payable in cash, percentage		5.75%
Interest rate, payable in additional notes, percentage		2.25%
Debt conversion, threshold of consecutive trading days | day	40
Debt conversion, converted instrument, amount | $	$ 55.4
Debt conversion, converted instrument, shares issued (in shares) | shares	98.5

Derivatives - Schedule of Fair

Derivatives - Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Derivative liabilities:
Total derivative liabilities	$ (4,585)	$ (146,865)
Compound embedded derivative with the 2013 8.00% Notes
Derivative liabilities:
Total derivative liabilities	(129)	(757)
Compound embedded derivative with the Loan Agreement with Thermo
Derivative liabilities:
Total derivative liabilities	$ (4,456)	$ (146,108)
Compound embedded derivative with the 2013 8.00% Notes
Derivatives, Fair Value [Line Items]
Loan interest rate, percentage	8.00%

Derivatives - Schedule of Deriv

Derivatives - Schedule of Derivative Gain (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain	$ 50,156	$ 39,059	$ 142,280	$ 145,944
Compound embedded derivative with the 2013 8.00% Notes
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain	159	322	628	709
Compound embedded derivative with the Loan Agreement with Thermo
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain	$ 49,997	$ 38,737	$ 141,652	$ 145,235
Compound embedded derivative with the 2013 8.00% Notes
Derivative Instruments, Gain (Loss) [Line Items]
Loan interest rate, percentage	8.00%		8.00%

Derivatives - Narrative (Detail

Derivatives - Narrative (Details)	1 Months Ended
	Jun. 30, 2009USD ($)contract	Sep. 30, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2013	May 20, 2013
8.00% Convertible Senior Notes Issued in 2013
Derivative [Line Items]
Loan interest rate, percentage		8.00%		8.00%	8.00%
Interest Rate Cap
Derivative [Line Items]
Number of interest rate cap agreements (in contracts) | contract	5
Maturity period	10 years
Derivative asset		$ 0	$ 0
Interest Rate Cap | Six-month LIBOR Rate
Derivative [Line Items]
Base rate to be capped, should the Base Rate not exceed 6.50%, percentage	5.50%
Interest on outstanding amounts on the Facility Agreement, percentage	6.50%
Base rate to be lowered from LIBOR, should the base rate exceed 6.50%, percentage	1.00%
Fee for interest rate cap agreements	$ 12,400,000

Fair Value Measurements - Recur

Fair Value Measurements - Recurring Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	$ (4,585)	$ (146,865)
Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(129)	(757)
Compound embedded derivative with the Loan Agreement with Thermo
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(4,456)	(146,108)
(Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
(Level 1) | Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
(Level 1) | Compound embedded derivative with the Loan Agreement with Thermo
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
(Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
(Level 2) | Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
(Level 2) | Compound embedded derivative with the Loan Agreement with Thermo
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
(Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(4,585)	(146,865)
(Level 3) | Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(129)	(757)
(Level 3) | Compound embedded derivative with the Loan Agreement with Thermo
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	$ (4,456)	$ (146,108)
Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loan interest rate, percentage	8.00%

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - contract	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2013	May 20, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Stock price, percentage decrease	(36.00%)
Stock issuance settlement period	40 days
(Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of derivatives (in contracts)	2
8.00% Convertible Senior Notes Issued in 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loan interest rate, percentage	8.00%	8.00%	8.00%

Fair Value Measurements - Deriv

Fair Value Measurements - Derivative Liabilities (Details)	Sep. 30, 2019$ / shares	Dec. 31, 2018$ / shares
Stock Price Volatility | Compound embedded derivative with the 2013 8.00% Notes | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.70	0.40
Stock Price Volatility | Compound embedded derivative with the 2013 8.00% Notes | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	1.30	1.20
Stock Price Volatility | Compound embedded derivative with the Loan Agreement with Thermo | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.70	0.40
Stock Price Volatility | Compound embedded derivative with the Loan Agreement with Thermo | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	1.30	1.20
Risk-Free Interest Rate | Compound embedded derivative with the 2013 8.00% Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.016	0.025
Risk-Free Interest Rate | Compound embedded derivative with the Loan Agreement with Thermo
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.016	0.025
Note Conversion Price | Compound embedded derivative with the 2013 8.00% Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.69	0.69
Note Conversion Price | Compound embedded derivative with the Loan Agreement with Thermo
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.69	0.69
Discount Rate | Compound embedded derivative with the 2013 8.00% Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage		0.28
Discount Rate | Compound embedded derivative with the 2013 8.00% Notes | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.11
Discount Rate | Compound embedded derivative with the 2013 8.00% Notes | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.27
Discount Rate | Compound embedded derivative with the Loan Agreement with Thermo
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.27	0.28
Market Price of Common Stock | Compound embedded derivative with the 2013 8.00% Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.41	0.64
Market Price of Common Stock | Compound embedded derivative with the Loan Agreement with Thermo
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liabilities, measurement input, percentage	0.41	0.64
Compound embedded derivative with the 2013 8.00% Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan interest rate, percentage	8.00%

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ (54,741)	$ (121,100)	$ (146,865)	$ (227,985)
Unrealized gain, included in derivative gain	50,156	39,059	142,280	145,944
Balance at end of period	$ (4,585)	$ (82,041)	$ (4,585)	$ (82,041)

Fair Value Measurements - Fai_2

Fair Value Measurements - Fair Value and Carrying Value of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 28, 2019	Dec. 31, 2018	Dec. 31, 2013	May 20, 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	$ 501,297		$ 463,451
Loan Agreement with Thermo
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loan interest rate, percentage		15.00%
Carrying Value	111,406		97,037
Loan Agreement with Thermo | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	111,406		97,037
Loan Agreement with Thermo | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Fair Value	$ 83,686		67,452
2013 8.00% Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loan interest rate, percentage	8.00%			8.00%	8.00%
Carrying Value	$ 1,394		1,379
2013 8.00% Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	1,394		1,379
2013 8.00% Notes | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Fair Value	$ 837		$ 734

Contingencies (Details)

Contingencies (Details) - USD ($) $ in Thousands	1 Months Ended			3 Months Ended			9 Months Ended
	Jan. 31, 2020	Jan. 31, 2019	May 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 05, 2019	Dec. 31, 2018
Loss Contingencies [Line Items]
Accounts payable				$ 36,839			$ 36,839			$ 23,085
Gain on legal settlement				0	$ 0		120	$ 6,779
Thermo Company
Loss Contingencies [Line Items]
Plaintiff's award				4,500			4,500		$ 4,500
Mudrick Capital Management, LP, et al. v. Monroe, et al.
Loss Contingencies [Line Items]
Retention limit				1,500			1,500
Loss contingency, receivable				4,800			4,800
Litigation settlement							4,500
Business Economic Loss Claim
Loss Contingencies [Line Items]
Proceeds from legal settlement		$ 3,700	$ 7,400
Gain on legal settlement						$ 6,800
Litigation settlement discount						$ 600
Scenario, Forecast | Business Economic Loss Claim
Loss Contingencies [Line Items]
Proceeds from legal settlement	$ 3,700
Customs and Border Protection tariff ruling
Loss Contingencies [Line Items]
Accounts payable				1,800			1,800
Customs and Border Protection tariff ruling, impact on inventory
Loss Contingencies [Line Items]
Accounts payable				900			900
Customs and Border Protection tariff ruling, excluding impact on inventory
Loss Contingencies [Line Items]
Accounts payable				900			900
Customs and Border Protection tariff ruling, impact on cost of goods sold
Loss Contingencies [Line Items]
Accounts payable				500			500
Customs and Border Protection tariff ruling, offsetting receivable
Loss Contingencies [Line Items]
Receivable				$ 400			$ 400

Related Party Transactions (Det

Related Party Transactions (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Jun. 28, 2019USD ($)	Feb. 28, 2019	Dec. 31, 2018USD ($)
Related Party Transaction [Line Items]
Payables to affiliates	$ 353,000		$ 353,000				$ 656,000
Debt instrument, principal amount outstanding	538,818,000		538,818,000				510,471,000
Fair value of compound derivative liability associated with the Loan Agreement	4,456,000		4,456,000				146,108,000
Loan Agreement with Thermo
Related Party Transaction [Line Items]
Debt instrument, principal amount outstanding	131,046,000		131,046,000		$ 62,000,000		119,702,000
Interest payable	2,400,000		2,400,000
Subordinated Loan Agreement
Related Party Transaction [Line Items]
Debt instrument, principal amount outstanding	64,423,000		64,423,000				0
Compound Embedded Derivative with the Thermo Loan Agreement
Related Party Transaction [Line Items]
Fair value of compound derivative liability associated with the Loan Agreement	4,500,000		4,500,000
Thermo
Related Party Transaction [Line Items]
Payables to affiliates							$ 700,000
Change in fair value related to equity issuance	100,000	$ 200,000	300,000	$ 600,000
Annual base rental payments	1,400,000		1,400,000
Annual rental payment escalation percentage						2.50%
Operating lease term						10 years
Rent expense	500,000		1,300,000
Thermo | Loan Agreement with Thermo
Related Party Transaction [Line Items]
Interest payable	87,500,000		87,500,000
Thermo | Compound Embedded Derivative with the Thermo Loan Agreement
Related Party Transaction [Line Items]
Interest expense, related party	3,900,000	$ 3,500,000	$ 11,300,000	$ 10,000,000
Thermo
Related Party Transaction [Line Items]
Equity method investment, threshold percentage requiring a Strategic Review Committee			0.45
Equity method investment, transaction threshold for approval requirement			$ 250,000
Thermo | Subordinated Loan Agreement
Related Party Transaction [Line Items]
Debt instrument, principal amount outstanding					$ 53,800,000
Interest payable	$ 2,100,000		$ 2,100,000

Earnings (Loss) Per Share (Deta

Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2013	May 20, 2013
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net income	$ 21,111	$ 6,189	$ 25,771	$ 9,019	$ (7,012)	$ 87,930	$ 53,071	$ 89,937
Effect of dilutive securities:
Loss to common stockholders plus assumed conversions	$ (24,226)			$ (25,625)			$ (75,220)	$ (45,685)
Weighted average common shares outstanding:
Basic shares outstanding (in shares)	1,451,703			1,264,516			1,450,146	1,263,416
Incremental shares from assumed exercises, conversions and other issuance of:
Stock options, restricted stock, restricted stock units and ESPP (in shares)	4,089			2,370			5,179	5,661
Diluted shares outstanding (in shares)	1,647,734			1,427,800			1,647,267	1,448,920
Net income (loss) per share:
Basic (USD per share)	$ 0.01			$ 0.01			$ 0.04	$ 0.07
Diluted (USD per share)	$ (0.01)			$ (0.02)			$ (0.05)	$ (0.03)
2013 8.00% Notes
Effect of dilutive securities:
Dilutive securities	$ (132)			$ (294)			$ (548)	$ (643)
Incremental shares from assumed exercises, conversions and other issuance of:
Conversion of debt securities (in shares)	2,021			1,867			2,021	2,087
Loan Agreement with Thermo
Effect of dilutive securities:
Dilutive securities	$ (45,205)			$ (34,350)			$ (127,743)	$ (134,979)
Incremental shares from assumed exercises, conversions and other issuance of:
Conversion of debt securities (in shares)	189,921			159,047			189,921	177,756
2013 8.00% Notes
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Loan interest rate, percentage	8.00%						8.00%		8.00%	8.00%

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information - Narrative (Details)	Sep. 30, 2019	Dec. 31, 2013	May 20, 2013
2013 8.00% Notes
Condensed Financial Statements, Captions [Line Items]
Loan interest rate, percentage	8.00%	8.00%	8.00%

Condensed Consolidating Finan_4

Condensed Consolidating Financial Information - Condensed Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue:
Revenue	$ 38,614			$ 35,692			$ 99,883	$ 98,167
Operating expenses:
Marketing, general and administrative	12,895			15,061			35,523	42,280
Revision to contract termination charge	0			0			0	(20,478)
Depreciation, amortization and accretion	24,026			24,738			71,679	66,585
Total operating expenses	50,619			53,654			146,875	127,139
Operating loss	(12,005)			(17,962)			(46,992)	(28,972)
Other income (expense):
Interest income and expense, net of amounts capitalized	(14,471)			(13,358)			(40,149)	(31,016)
Derivative gain (loss)	50,156			39,059			142,280	145,944
Gain on legal settlement	0			0			120	6,779
Equity in subsidiary earnings (loss)	0			0			0	0
Other	(2,529)			1,331			(2,064)	(2,682)
Total other income (expense)	33,156			27,032			100,187	119,025
Income before income taxes	21,151			9,070			53,195	90,053
Income tax expense	40			51			124	116
Net income	21,111	$ 6,189	$ 25,771	9,019	$ (7,012)	$ 87,930	53,071	89,937
Comprehensive income (loss)	22,133			9,519			53,325	92,737
Service revenue
Revenue:
Revenue	34,152			29,898			86,971	83,903
Operating expenses:
Cost of goods and services	9,216			9,429			28,464	27,984
Subscriber equipment sales
Revenue:
Revenue	4,462			5,794			12,912	14,264
Operating expenses:
Cost of goods and services	4,482			4,426			11,209	10,768
Reportable Legal Entities | Parent Company
Revenue:
Revenue	21,955			23,010			67,648	67,065
Operating expenses:
Marketing, general and administrative	8,522			10,706			22,297	29,173
Revision to contract termination charge								(20,478)
Depreciation, amortization and accretion	23,371			25,041			69,721	65,434
Total operating expenses	38,665			42,748			113,297	94,338
Operating loss	(16,710)			(19,738)			(45,649)	(27,273)
Other income (expense):
Interest income and expense, net of amounts capitalized	(14,445)			(13,360)			(40,101)	(31,081)
Derivative gain (loss)	50,156			39,059			142,280	145,944
Gain on legal settlement							120	6,779
Equity in subsidiary earnings (loss)	2,761			3,170			(2,452)	(3,950)
Other	(651)			(112)			(1,127)	(482)
Total other income (expense)	37,821			28,757			98,720	117,210
Income before income taxes	21,111			9,019			53,071	89,937
Income tax expense	0			0			0	0
Net income	21,111			9,019			53,071	89,937
Comprehensive income (loss)	21,111			9,019			53,071	89,937
Reportable Legal Entities | Parent Company | Service revenue
Revenue:
Revenue	21,493			22,750			66,485	66,554
Operating expenses:
Cost of goods and services	6,555			6,825			20,571	19,827
Reportable Legal Entities | Parent Company | Subscriber equipment sales
Revenue:
Revenue	462			260			1,163	511
Operating expenses:
Cost of goods and services	217			176			708	382
Reportable Legal Entities | Guarantor Subsidiaries
Revenue:
Revenue	17,527			16,771			43,659	43,534
Operating expenses:
Marketing, general and administrative	1,371			1,468			3,928	3,989
Revision to contract termination charge								0
Depreciation, amortization and accretion	17			52			20	216
Total operating expenses	7,923			7,335			19,702	18,999
Operating loss	9,604			9,436			23,957	24,535
Other income (expense):
Interest income and expense, net of amounts capitalized	(5)			(5)			(12)	(9)
Derivative gain (loss)	0			0			0	0
Gain on legal settlement							0	0
Equity in subsidiary earnings (loss)	(3,427)			(2,571)			(12,050)	(12,199)
Other	200			23			327	140
Total other income (expense)	(3,232)			(2,553)			(11,735)	(12,068)
Income before income taxes	6,372			6,883			12,222	12,467
Income tax expense	7			5			33	21
Net income	6,365			6,878			12,189	12,446
Comprehensive income (loss)	6,365			6,878			12,189	12,446
Reportable Legal Entities | Guarantor Subsidiaries | Service revenue
Revenue:
Revenue	13,173			11,627			32,067	30,993
Operating expenses:
Cost of goods and services	1,645			1,556			4,472	4,444
Reportable Legal Entities | Guarantor Subsidiaries | Subscriber equipment sales
Revenue:
Revenue	4,354			5,144			11,592	12,541
Operating expenses:
Cost of goods and services	4,890			4,259			11,282	10,350
Reportable Legal Entities | Non- Guarantor Subsidiaries
Revenue:
Revenue	21,445			18,610			55,634	53,195
Operating expenses:
Marketing, general and administrative	22,063			22,911			67,861	67,852
Revision to contract termination charge								0
Depreciation, amortization and accretion	638			(355)			1,938	935
Total operating expenses	26,345			26,282			80,937	79,469
Operating loss	(4,900)			(7,672)			(25,303)	(26,274)
Other income (expense):
Interest income and expense, net of amounts capitalized	(21)			7			(36)	24
Derivative gain (loss)	0			0			0	0
Gain on legal settlement							0	0
Equity in subsidiary earnings (loss)	0			0			0	0
Other	(2,075)			1,431			(1,258)	(2,302)
Total other income (expense)	(2,096)			1,438			(1,294)	(2,278)
Income before income taxes	(6,996)			(6,234)			(26,597)	(28,552)
Income tax expense	33			46			91	95
Net income	(7,029)			(6,280)			(26,688)	(28,647)
Comprehensive income (loss)	(6,017)			(5,906)			(26,436)	(25,945)
Reportable Legal Entities | Non- Guarantor Subsidiaries | Service revenue
Revenue:
Revenue	19,767			16,915			50,880	48,929
Operating expenses:
Cost of goods and services	2,238			2,429			7,325	7,591
Reportable Legal Entities | Non- Guarantor Subsidiaries | Subscriber equipment sales
Revenue:
Revenue	1,678			1,695			4,754	4,266
Operating expenses:
Cost of goods and services	1,406			1,297			3,813	3,091
Eliminations
Revenue:
Revenue	(22,313)			(22,699)			(67,058)	(65,627)
Operating expenses:
Marketing, general and administrative	(19,061)			(20,024)			(58,563)	(58,734)
Revision to contract termination charge								0
Depreciation, amortization and accretion	0			0			0	0
Total operating expenses	(22,314)			(22,711)			(67,061)	(65,667)
Operating loss	1			12			3	40
Other income (expense):
Interest income and expense, net of amounts capitalized	0			0			0	50
Derivative gain (loss)	0			0			0	0
Gain on legal settlement							0	0
Equity in subsidiary earnings (loss)	666			(599)			14,502	16,149
Other	(3)			(11)			(6)	(38)
Total other income (expense)	663			(610)			14,496	16,161
Income before income taxes	664			(598)			14,499	16,201
Income tax expense	0			0			0	0
Net income	664			(598)			14,499	16,201
Comprehensive income (loss)	674			(472)			14,501	16,299
Eliminations | Service revenue
Revenue:
Revenue	(20,281)			(21,394)			(62,461)	(62,573)
Operating expenses:
Cost of goods and services	(1,222)			(1,381)			(3,904)	(3,878)
Eliminations | Subscriber equipment sales
Revenue:
Revenue	(2,032)			(1,305)			(4,597)	(3,054)
Operating expenses:
Cost of goods and services	$ (2,031)			$ (1,306)			$ (4,594)	$ (3,055)

Condensed Consolidating Finan_5

Condensed Consolidating Financial Information - Balance Sheet (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 26,225			$ 15,212
Restricted cash	61,224			60,278
Accounts receivable, net of allowance	20,909			19,327
Intercompany receivables	0			0
Inventory	17,240			14,274
Prepaid expenses and other current assets	20,916			13,410
Total current assets	146,514			122,501
Property and equipment, net	820,315			882,695
Operating lease right of use assets, net	16,270			0
Intercompany notes receivable	0			0
Investment in subsidiaries	0			0
Intangible and other assets, net	36,744			40,286
Total assets	1,019,843			1,045,482
Current liabilities:
Current portion of long-term debt	98,829			96,249
Accounts payable	5,019			6,995
Accrued expenses	36,839			23,085
Intercompany payables	0			0
Payables to affiliates	353			656
Derivative liabilities	129			757
Deferred revenue	27,839			31,938
Total current liabilities	169,008			159,680
Long-term debt, less current portion	402,468			367,202
Operating lease liabilities	15,158			0
Employee benefit obligations	4,619			4,489
Intercompany notes payable	0			0
Derivative liabilities	4,456			146,108
Deferred revenue	5,261			5,692
Other non-current liabilities	2,731			3,366
Total non-current liabilities	434,693			526,857
Stockholders’ equity (deficit)	416,142	$ 392,886	$ 385,375	358,945	$ 392,100	$ 381,343	$ 383,991	$ 291,224
Total liabilities and stockholders’ equity	1,019,843			1,045,482
Reportable Legal Entities | Parent Company
Current assets:
Cash and cash equivalents	22,238			11,312
Restricted cash	61,224			60,278
Accounts receivable, net of allowance	7,067			7,138
Intercompany receivables	1,085,038			1,047,320
Inventory	6,061			6,747
Prepaid expenses and other current assets	11,269			7,765
Total current assets	1,192,897			1,140,560
Property and equipment, net	790,615			850,790
Operating lease right of use assets, net	11,965
Intercompany notes receivable	5,674			5,600
Investment in subsidiaries	(249,110)			(255,187)
Intangible and other assets, net	31,583			36,275
Total assets	1,783,624			1,778,038
Current liabilities:
Current portion of long-term debt	98,829			96,249
Accounts payable	1,683			2,420
Accrued expenses	19,953			8,904
Intercompany payables	816,507			778,340
Payables to affiliates	353			656
Derivative liabilities	129			757
Deferred revenue	1,669			1,699
Total current liabilities	939,123			889,025
Long-term debt, less current portion	402,468			367,202
Operating lease liabilities	11,602
Employee benefit obligations	4,619			4,489
Intercompany notes payable	0			6,436
Derivative liabilities	4,456			146,108
Deferred revenue	5,080			5,339
Other non-current liabilities	134			494
Total non-current liabilities	428,359			530,068
Stockholders’ equity (deficit)	416,142			358,945
Total liabilities and stockholders’ equity	1,783,624			1,778,038
Reportable Legal Entities | Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	159			2,126
Restricted cash	0			0
Accounts receivable, net of allowance	8,697			7,826
Intercompany receivables	860,279			824,920
Inventory	9,023			6,149
Prepaid expenses and other current assets	6,423			2,987
Total current assets	884,581			844,008
Property and equipment, net	1,105			1,242
Operating lease right of use assets, net	217
Intercompany notes receivable	0			0
Investment in subsidiaries	42,618			42,481
Intangible and other assets, net	246			324
Total assets	928,767			888,055
Current liabilities:
Current portion of long-term debt	0			0
Accounts payable	2,393			3,378
Accrued expenses	9,699			6,747
Intercompany payables	849,900			832,284
Payables to affiliates	0			0
Derivative liabilities	0			0
Deferred revenue	20,673			23,943
Total current liabilities	882,665			866,352
Long-term debt, less current portion	0			0
Operating lease liabilities	182
Employee benefit obligations	0			0
Intercompany notes payable	0			0
Derivative liabilities	0			0
Deferred revenue	158			335
Other non-current liabilities	322			323
Total non-current liabilities	662			658
Stockholders’ equity (deficit)	45,440			21,045
Total liabilities and stockholders’ equity	928,767			888,055
Reportable Legal Entities | Non- Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	3,828			1,774
Restricted cash	0			0
Accounts receivable, net of allowance	5,145			4,363
Intercompany receivables	90,528			105,819
Inventory	2,156			1,378
Prepaid expenses and other current assets	3,224			2,658
Total current assets	104,881			115,992
Property and equipment, net	28,591			30,658
Operating lease right of use assets, net	4,088
Intercompany notes receivable	0			6,436
Investment in subsidiaries	57,472			50,220
Intangible and other assets, net	4,927			3,698
Total assets	199,959			207,004
Current liabilities:
Current portion of long-term debt	0			0
Accounts payable	943			1,197
Accrued expenses	7,187			7,434
Intercompany payables	369,380			367,396
Payables to affiliates	0			0
Derivative liabilities	0			0
Deferred revenue	5,497			6,296
Total current liabilities	383,007			382,323
Long-term debt, less current portion	0			0
Operating lease liabilities	3,374
Employee benefit obligations	0			0
Intercompany notes payable	5,674			5,600
Derivative liabilities	0			0
Deferred revenue	23			18
Other non-current liabilities	2,275			2,549
Total non-current liabilities	11,346			8,167
Stockholders’ equity (deficit)	(194,394)			(183,486)
Total liabilities and stockholders’ equity	199,959			207,004
Eliminations
Current assets:
Cash and cash equivalents	0			0
Restricted cash	0			0
Accounts receivable, net of allowance	0			0
Intercompany receivables	(2,035,845)			(1,978,059)
Inventory	0			0
Prepaid expenses and other current assets	0			0
Total current assets	(2,035,845)			(1,978,059)
Property and equipment, net	4			5
Operating lease right of use assets, net	0
Intercompany notes receivable	(5,674)			(12,036)
Investment in subsidiaries	149,020			162,486
Intangible and other assets, net	(12)			(11)
Total assets	(1,892,507)			(1,827,615)
Current liabilities:
Current portion of long-term debt	0			0
Accounts payable	0			0
Accrued expenses	0			0
Intercompany payables	(2,035,787)			(1,978,020)
Payables to affiliates	0			0
Derivative liabilities	0			0
Deferred revenue	0			0
Total current liabilities	(2,035,787)			(1,978,020)
Long-term debt, less current portion	0			0
Operating lease liabilities	0
Employee benefit obligations	0			0
Intercompany notes payable	(5,674)			(12,036)
Derivative liabilities	0			0
Deferred revenue	0			0
Other non-current liabilities	0			0
Total non-current liabilities	(5,674)			(12,036)
Stockholders’ equity (deficit)	148,954			162,441
Total liabilities and stockholders’ equity	$ (1,892,507)			$ (1,827,615)

Condensed Consolidating Finan_6

Condensed Consolidating Financial Information - Statement of Cash Flows (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by (used in) operating activities	$ 6,044	$ 19,768
Cash flows provided by (used in) investing activities:
Second-generation network costs (including interest)	(1,350)	(5,887)
Property and equipment additions	(3,480)	(5,346)
Investment in business	155	0
Purchase of intangible assets	(2,950)	(1,948)
Net cash used in investing activities	(7,625)	(13,181)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	(47,435)	(38,933)
Payments for financing costs	(1,401)	0
Proceeds from Subordinated Loan Agreement	62,000
Proceeds from issuance of common stock and exercise of options and warrants	402	395
Net cash provided by (used in) financing activities	13,566	(38,538)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(26)	68
Net increase (decrease) in cash, cash equivalents and restricted cash	11,959	(31,883)
Cash, cash equivalents and restricted cash, beginning of period	75,490	105,279
Cash, cash equivalents and restricted cash, end of period	87,449	73,396
Reportable Legal Entities | Parent Company
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by (used in) operating activities	4,521	11,458
Cash flows provided by (used in) investing activities:
Second-generation network costs (including interest)	(1,309)	(4,629)
Property and equipment additions	(3,068)	(4,140)
Investment in business	155
Purchase of intangible assets	(1,993)	(1,904)
Net cash used in investing activities	(6,215)	(10,673)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	(47,435)	(38,933)
Payments for financing costs	(1,401)
Proceeds from Subordinated Loan Agreement	62,000
Proceeds from issuance of common stock and exercise of options and warrants	402	395
Net cash provided by (used in) financing activities	13,566	(38,538)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	11,872	(37,753)
Cash, cash equivalents and restricted cash, beginning of period	71,590	96,499
Cash, cash equivalents and restricted cash, end of period	83,462	58,746
Reportable Legal Entities | Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by (used in) operating activities	(1,659)	7,412
Cash flows provided by (used in) investing activities:
Second-generation network costs (including interest)	0	0
Property and equipment additions	(308)	(900)
Investment in business	0
Purchase of intangible assets	0	0
Net cash used in investing activities	(308)	(900)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	0	0
Payments for financing costs	0
Proceeds from Subordinated Loan Agreement	0
Proceeds from issuance of common stock and exercise of options and warrants	0	0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	(1,967)	6,512
Cash, cash equivalents and restricted cash, beginning of period	2,126	4,942
Cash, cash equivalents and restricted cash, end of period	159	11,454
Reportable Legal Entities | Non- Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by (used in) operating activities	3,182	898
Cash flows provided by (used in) investing activities:
Second-generation network costs (including interest)	(41)	(1,258)
Property and equipment additions	(104)	(306)
Investment in business	0
Purchase of intangible assets	(957)	(44)
Net cash used in investing activities	(1,102)	(1,608)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	0	0
Payments for financing costs	0
Proceeds from Subordinated Loan Agreement	0
Proceeds from issuance of common stock and exercise of options and warrants	0	0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(26)	68
Net increase (decrease) in cash, cash equivalents and restricted cash	2,054	(642)
Cash, cash equivalents and restricted cash, beginning of period	1,774	3,838
Cash, cash equivalents and restricted cash, end of period	3,828	3,196
Eliminations
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by (used in) operating activities	0	0
Cash flows provided by (used in) investing activities:
Second-generation network costs (including interest)	0	0
Property and equipment additions	0	0
Investment in business	0
Purchase of intangible assets	0	0
Net cash used in investing activities	0	0
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	0	0
Payments for financing costs	0
Proceeds from Subordinated Loan Agreement	0
Proceeds from issuance of common stock and exercise of options and warrants	0	0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	0	0
Cash, cash equivalents and restricted cash, beginning of period	0	0
Cash, cash equivalents and restricted cash, end of period	$ 0	$ 0

Uncategorized Items - gsat-2019

Label	Element	Value
Restricted Cash	us-gaap_RestrictedCash	$ 60,278,000
Restricted Cash	us-gaap_RestrictedCash	61,224,000
Accounting Standards Update 2014-09 [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	3,093,000
Accounting Standards Update 2014-09 [Member] | Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 3,093,000